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ABSTRACT OF DISSERTATION

THE ROLE OF INTESTINAL EPITHELIAL CELLS AND THE REGULATION OF
THE POLYMERIC IMMUNOGLOBULIN RECEPTOR IN HOMEOSTASIS AND
INFLAMMATION
The mammalian intestine harbors an estimated 100 trillion microorganisms,
which normally maintain a mutually beneficial relationship with the host. The intestinal
epithelium consists of a single layer of intestinal epithelial cells (IECs) that provides a
physical barrier as well as innate immune defense, preventing this vast community of
microbes from entering host tissues. Secretory immunoglobulin A (SIgA) acts as the first
line of antigen-specific immunity at the interface between the gut microbiota and the
intestinal epithelium. Polymeric IgA secreted by plasma cells in the intestinal lamina
propria is transported across IECs by the polymeric immunoglobulin receptor (pIgR).
Defects in epithelial barrier and immune functions can lead to infections with
opportunistic and pathogenic microbes and contribute to the etiology of inflammatory
bowel disease (IBD). Here we investigate the ability of IEC biomarkers to define the
mechanism and severity of intestinal inflammation, as well as provide insight into the
function of IEC in regulating intestinal homeostasis and inflammation. Importantly,
down-regulation of pIgR expression was a common feature in human IBD and mouse
models of experimental colitis. One molecule of pIgR is consumed for every molecule of
SIgA transported, thus high expression of pIgR is required to maintain sufficient supply
of SIgA. Accordingly, we investigate the mechanisms by which IECs regulate pIgR
expression in response to colonic bacteria. Cross-talk between the microbiota and IECs is
mediated by pattern recognition receptors, including Toll-like receptors (TLR), leading to
expression of gene products that enhance epithelial barrier function and innate immunity.
The cytoplasmic adaptor protein MyD88 transduces signals from TLRs that recognize
bacterial products. We show that pIgR induction by colonic bacteria is dependent on
TLR4-MyD88 activation of NF-κB signaling. We examined the role of epithelialspecific MyD88 signaling in antibacterial immunity and epithelial expression of key gene
products that participate in innate immunity in the gut by generating mice with an IECtargeted deletion of the Myd88 gene (MyD88∆IEC). MyD88∆IEC mice display
immunological and antimicrobial defects resulting in increased susceptibility to
experimental colitis. We conclude that cross-talk between bacteria and IECs via MyD88dependent signaling is crucial for maintenance of gut homeostasis.
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Chapter One: Introduction
“Good fences make good neighbors.”~ Robert Frost
This mid 17th –century proverb was used by Robert Frost in his 1914 poem
“Mending Wall”, in which Frost questions whether rebuilding a stone wall each spring
between his and his neighbor’s property is actually necessary to maintain good will
between neighbors. While it seems that Frost doubts a physical barrier is required to
maintain these relationships, in the intestine, this proverb can be taken literally. The
intestinal epithelium, composed of a single layer of intestinal epithelial cells (IECs),
provides a biological “fence” that separates the vast number of bacteria in the intestinal
lumen from host tissue. In addition to this physical barrier, IECs must also provide
immunological defenses to maintain a symbiotic relationship between microbiota and
host. When these fences and active defenses fail, intestinal inflammation can result. In
this work, the critical role of IECs in regulating intestinal homeostasis and inflammation
is investigated.

Structure and Function of the Intestinal Epithelium – “The Good Fence”
Epithelial surfaces, including the skin, respiratory tract, gastrointestinal tract and
urinary tract, make up the main interfaces between the host and external environment1.
The primary function of these epithelial surfaces is to provide a physical and
immunological barrier to prevent invasion by microorganisms, with which these surfaces
are in constant contact. The quantity and composition of these microorganisms vary
based on the anatomical site2. In particular, the gastrointestinal tract (GI) is the largest
reservoir of commensal microorganisms in the mammalian body. It is estimated that the
1

mammalian gut is home to 1014 bacteria, with at least 1,000 different bacterial species3.
Bacterial concentrations within the GI tract increase exponentially as it descends from the
stomach to the distal colon4. The upper GI tract, including the stomach, duodenum,
jejunum and proximal small intestine contains minimal bacterial loads of fewer than 104
per gram of luminal contents5. The bacterial concentrations increase towards the lower
small intestine, reaching levels of about 107 and 108 cells per gram, while bacterial loads
increase to approximately 1011 bacteria per gram of stool in the colon4. A single layer of
intestinal epithelial cells, known collectively as the intestinal epithelium, provides a
physical barrier that separates the vast number of bacteria in the intestinal lumen from the
underlying lamina propria1. The intestinal epithelium consists of four major cell lineages
that arise from a pluripotent stem cell progenitor. These include absorptive enterocytes,
which make-up the majority of intestinal epithelial cells (IECs), the mucus-producing
goblet cells, enteroendocrine cells, which are specialized hormone-producing endocrine
cells in the gastrointestinal tract, and Paneth cells, which are the main producers of
antimicrobial peptides3 (Figure 1-1). IECs are structurally and functionally polarized,
with an apical surface facing the intestinal lumen and a basolateral surface facing the
underlying lamina propria6. These epithelial cells constitute a large surface area,
approximately 100m2 for an average human, which is structurally organized by the cryptvillus axis. The turnover rate of IECs, which is approximately 3-5 days, is governed by
the rate of cell proliferation in the crypt as well as the cell shedding at the villus surface3.
Intestinal stem cells located in the crypt regions undergo proliferation and differentiation
into enterocytes, enteroendocrine cells, or goblet cells and migrate upward to the top of
the villus where cellular apoptosis and epithelial shedding occurs. Intestinal stem cells
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can also differentiate into Paneth cells that migrate downward to the bottoms of the crypts
(Figure 1-1). During intestinal epithelial cell differentiation and migration, the formation
of epithelial tight junctions (TJ) occurs at cell-cell contact sites to ensure a virtually
impermeable barrier. Accordingly, in a healthy gut, the proper expression and formation
of TJ proteins are the limiting factor that regulates intestinal permeability5. Therefore this
well organized structure of the intestinal epithelium creates a secure fence that separates
the neighboring microbiota from the neighboring lamina propria.

Neighbors to the North – The Intestinal Microbiota
While the primary function of IECs is to maintain spatial separation between
bacteria and host tissue, thus preventing bacterial invasion and infection, the majority of
intestinal bacteria maintain a symbiotic relationship with the host. The colonic
microbiota break down complex carbohydrates that cannot be metabolized by the host7;
bacterial fermentation generates short-chain fatty acids that serve as energy sources for
colonic ECs7; colonic bacteria produce antimicrobial peptides that promote the
maintenance of a symbiotic community8; and the presence of commensal bacteria protect
against pathogen colonization by competing for nutrients and space9. Additionally,
communication between commensal bacteria and IECs has been shown to control the rate
of epithelial turnover and differentiation, enhance epithelial barrier function and shapes
the developing mucosal immune system3,10.
Interestingly, humans are born germ-free but the GI tract is rapidly colonized after
birth11. The gut microbiota is highly diverse, with 15,000-36000 identified species and at
least 1,000 different species present in the microbiota of each individual3. However, it is
3

believed that only 30-40 bacterial species represent greater than 99% of an individual’s
microbiota12. The four major bacteria phyla found in the colonic mucus include
Firmicutes (~64%), Bacteriodetes (~23%), Proteobacteria (~8%) and Actinobacteria
(~5%). While the microbiota generally lives in a symbiotic relationship with the host,
these bacteria can contribute to disease. Accordingly, the presence of bacteria is required
for the development of disease in at least 20 well characterized mouse models of
experimental colitis13,14. While techniques to analyze the composition of the microbiota
are variable, a general “dysbiosis,” or imbalance in the composition of the microbiota, is
observed in patients with inflammatory bowel disease (IBD)15. Increases in adherent and
invasive Escherichia coli along with reduced colonization of members of Firmicutes and
Bacteriodetes have been found in IBD patients compared to healthy individuals15-17.
However, whether this dysbiosis is a cause or an effect of intestinal inflammation is still
under investigation14,18.

Neighbors to the South- Immune Cells of the Lamina Propria
Beneath the intestinal epithelium and separated from the microbiota, a layer of
mucosal tissue, known as the lamina propria, is a major mucosal effector site that
functions to recruit T and B cells emerging inductive sites19. The lamina propria is
composed of stromal cells (mostly myofibroblasts) and immune cells including B cells, T
cells, macrophages and dendritic cells (DCs) (Figure 1-2)6. As mentioned, the intestinal
epithelial barrier in a healthy gut does not allow penetration of commensal bacteria into
the lamina propria, thus preventing excessive immune responses. However, limited
bacteria-immune cell interactions occur in a control manner in specialized lymphoid
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structures, including Peyer’s patches (PPs) of the small intestine and isolated lymphoid
follicles located throughout the length of the intestinal tract19. These inductive sites are
located beneath specialized cells within the epithelium known as microfold (M) cells. M
cells are capable of transporting luminal contents, including commensal bacteria, to
resident antigen presenting cells (mostly DCs) within the PP or lymphoid follicle (Figure
1-2)6. Bacterial-laden DCs can then migrate to PP and mesenteric lymph nodes (MLNs)
where they can induce B and T cells to undergo clonal expansion and differentiation upon
activation by antigen. The presence of the microbiota also has a strong influence on the
development of these secondary lymphoid structures that make-up the mucosal associated
lymphoid tissue (MALT) and gut-associated lymphoid tissue (GALT)20. Germ-free mice
exhibit defective MALT and GALT development, including reduced numbers of PPs and
smaller PPs, smaller and fewer cellular mesenteric lymph nodes (MLNs) and less cellular
lamina propria, as compared to conventionally raised mice21-23.

Toll-like Receptor Signaling Provides Communication Between Neighbors
Cross talk between bacteria and host cells is mediated by pattern recognition
receptors (PRRs). Toll-like receptors (TLRs) are a family of PRRs that recognize
pathogen-associated molecular patterns (PAMPs)6. While the general term PAMP is
used for these TLR ligands, the molecular patterns that are actually recognized by these
TLRs are not just from pathogens, but commensal bacteria, viruses and endogenous
proteins as well. There are 13 characterized TLRs, 10 of which are homologous between
mice and humans (Figure 1-3)6. The TLRs that are primarily responsible for recognizing
bacterial products, including TLR1 (bacterial lipoproteins), TLR2 (bacterial lipoproteins,
5

peptidoglycans), TLR4 (lipopolysaccharide (LPS), TLR5 (flagellin) and TLR6 (LTA,
diacyl lipoproteins), are generally expressed on the cell surface6,24. Alternatively, the
TLRs that are primarily responsible for the recognition of viral components, including
TLR3 (dsRNA), TLR7 (ssRNA), TLR8 (ssRNA), and TLR9 (bacterial/viral
unmethylated CpG DNA), are generally expressed on intracellular endosomal
membranes6. TLRs are inducible or constitutively expressed, at various levels and
combinations, in all cell-types throughout the intestine24. However, given the close
association between IECs and the microbiota, TLR signaling by IEC provide the first line
of communication between bacteria and host.
All TLRs are type 1 transmembrane receptors that contain an N-terminal leucinerich repeat domain (LRR), a transmembrane region and a C-terminal cytoplasmic
domain6,25. The C-terminal domain shares high homology to the type-1 IL-1 receptor and
is thus termed the Toll/IL-1R (TIR) domain26. Upon ligation of TLRs with an
appropriate ligand, signaling cascades are activated, resulting in the innate immune
effector responses as well as the initiation of adaptive immune responses. Stimulation of
TLRs leads to the recruitment of cytoplasmic adaptor proteins25. Five adaptor proteins
have been identified; myeloid differentiation factor 88 (MyD88), MyD88-adaptor like
protein (Mal/TIRAP), TIR-containing adaptor protein inducing interferon-β (TRIF), Trifrelated adaptor molecule (TRAM) and sterile α- and armadillo-motif containing protein
(SARM)25. MyD88 is utilized by all TLRs, except TLR3. TRIF is utilized by TLR3 as
well as TLR4. Accordingly, unlike other TLRs, TLR4 utilizes both MyD88 and TRIF via
recruitment of the bridging adaptors Mal and TRAM (Figure 1-4). These adaptor
proteins initiate signaling cascades that ultimately lead to the activation of the nuclear
6

factor –κB (NF-κB)27 signaling pathways and parallel activation of several mitogenactivated protein kinases (MAPK) including c-Jun N-terminal kinase (JNK), extracellular
signal-regulated kinase ERK (ERK), and p38 MAPK26. Activation of these signaling
pathways leads to the induction of pro-inflammatory chemokines, cytokines and
antimicrobial peptides6,17. Accordingly, NF-κB and MAPK activation is significantly
reduced in MyD88-deficient mice28. Along with the activation of NF-κB and MAPK, the
MyD88-independent, Trif-dependent signaling pathway leads to the phosphorylation and
translocation of IRF3 to the nucleus where it regulates the expression of type 1
interferons (IFN)26 (Figure 1-4). TLR signaling has been shown to enhance epithelial
barrier function by inducing expression of tight junction proteins, mucin production,
antimicrobial peptides and protection against epithelial apoptosis6. Intestinal epithelial
cells of germ-free mice have reduced expression of TLRs, as compared to conventionally
raised mice29, suggesting a role for the microbiota in maintaining innate immune
function.
The transcription factor NF-κB is a central regulator of inflammatory and immune
responses in most organ systems. Inactive NF-κB is localized to the cytosol, complexed
to the inhibitory protein IκB30. Upon stimulation, including TLR signaling, IκB is
phosphorylated by IκB Kinase (IKK) and degraded, allowing NF-κB translocation to the
nucleus and induction of gene transcription30,31. In the intestine, NF-κB signaling has
diverse functions that govern both protective and destructive immune responses.
Whether these effects are beneficial or harmful depend on the cell type involved, the
level of NF-κB activation as well the specific environmental and pathophysiological
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conditions. While excessive NF-κB signaling in immune cells has been implicated as a
major contributor to intestinal inflammation, recent studies have indicated that NF-κB
signaling in IEC is required to maintain intestinal homeostasis30,32,33. Epithelial deletion
of NEMO, the common regulatory subunit of the NF-κB IKK complex, causes excessive
intestinal epithelial apoptosis and epithelial barrier defects leading to the translocation of
commensal bacteria34. Accordingly, a balance of NF-κB signaling must be maintained to
achieve a protective level of “physiological” inflammation.

Mucus Layer Provides a Preliminary Line of Defense
To support this epithelial barrier, a mucus layer covers the single layer of
intestinal epithelial cells within the small intestine and colon. This mucus layer is
composed of transmembrane molecules known as mucins35. The main mucin protein and
primary structural component of mucus is mucin-2 (MUC2), a large gel-forming protein
(>100 MDa) produced by goblet cells. Once released from the apical side of the goblet
cell, MUC2 molecules dimerize and trimerize to form a large network, which can be
further cross-linked to form a well organized and stable structure35. Interestingly, the
small intestine and colon contain very distinct mucus layer properties. The colon is
protected by an inner and outer mucus layer36. The thick inner mucus layer is relatively
sterile and firmly attached to the epithelium. This inner layer is continuously converted
to a less dense outer mucus layer that is permeable to commensal bacteria35. In contrast,
the mucus layer of the small intestine is thin and is relatively permeable to the sparse
bacterial loads found in this area35. These differences in mucus properties are consistent
with the difference in bacterial concentrations as well as anatomical functions of these
8

two organs5. For example, a dense, tightly bound mucus layer would be detrimental for
the small intestine, whose primary function is to chemically digest and absorb nutrients
from ingested food. On the other hand, the presence of the compacted inner mucus layer
in the colon facilitates the effective passage of waste and prevents bacteria association
with the epithelial surface. Accordingly, mice deficient in Muc2 demonstrate increase
epithelial permeability and bacteria penetration of the intestinal epithelium37,38.

An Epithelial Immune Barrier Reinforces the Physical Barrier
In addition to forming an impermeable physical barrier, IECs also actively
maintain an immunological barrier to prevent bacterial penetration. IECs secrete a broad
range of antimicrobial peptides (AMPs), including defensins, cathelicidins and
calprotectins that exhibit broad-spectrum antibiotic activity against bacteria, fungi,
viruses and yeast3. These small cationic peptides are secreted into the lumen of the gut in
response to microbial stimulation1. Once in the mucus layer, the majority of AMPs can
insert themselves into bacterial membranes, resulting in bacterial cell lysis1. Analyses of
antimicrobial activity in luminal contents indicate that AMPs are retained in the mucus
layer and are not found in the lumen39. Accordingly, a diffusion barrier is created that
concentrates levels of AMPs near the epithelial surface, increasing the effectiveness of
these proteins in the protection of the epithelium from bacterial adherence and
penetration40. All IEC lineages produce and secrete AMPs, although Paneth cells located
in the epithelial crypts are known to be the main source of AMPs1,35. Several AMPs are
constitutively expressed, including many defensins, while some subsets of AMPs require
TLR activation by specific bacterial subsets40. MyD88-deficient mice have undetectable
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levels of the AMP regenerating islet-derived protein 3γ (RegIIIγ)41 and it has recently
been shown that RegIIIγ expression was reduced in the small intestine of mice with an
epithelial deletion of MyD8842. Furthermore, in the absence of MyD88 or Paneth cell
development there is an increase in the translocation of commensal and pathogenic
bacteria43. Taken together, these results suggest that bacterial-IEC cross-talk mediated by
MyD88 signaling is crucial for the expression of AMPs that limit the invasion of
commensal and pathogenic bacteria. However, the role of epithelial MyD88 signaling in
regulating antimicrobial activity in the colon has not been investigated.

SIgA Provides the First Line of Antigen-Specific Defense
Secretory antibodies of the IgA class (SIgA) provide the first line of antigenspecific immune protection in the gut against potential pathogens44. SIgA antibodies in
mucosal secretions contribute to intestinal homeostasis by limiting access of microbial
and environmental antigens to the host tissue, maintaining the integrity of the epithelial
barrier and shaping the composition of the commensal microbiota45,46. IgA is the
predominant antibody isotype in mucosal tissues and comprises approximately 75% of
the total antibody production in the mammalian body. However, IgA antibodies are a
minor component of serum (systemic) antibodies, which highlights the importance of the
mucosal immune system in human immunity47. There is a clear association between the
commensal microbiota and the induction of IgA responses. IgA levels in mucosal
secretions and the number of IgA-producing plasma cells in the lamina propria are
increased several orders of magnitude between colonized and germ-free mice of the same
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strain48. Thus, the significant induction of intestinal IgA in the presence of commensal
bacteria supports a major role for IgA in protection at these mucosal sites.
The production of IgA-specific for commensal bacteria can occur via several well
orchestrated interactions between bacteria and immune cells within the GALT49 (Figure
1-5). DCs in the PPs and lymphoid follicles capture bacteria internalized by M cells and
migrate to the interfollicular region of the PPs or MLNs where they present antigen to
CD4+ T cells. Antigen-activated T cells can induce B cells to differentiate into IgA+
plasma cells that home, by means of α4B7, CCR9 and/or CCR10 expression, to the
lamina propria1,4. T-cell independent IgA responses have also been demonstrated47,50.
The intestinal lamina propria also contains IgM+ B cells that are thought to be a
precursor of IgA-producing plasma cells51. Lamina propria DCs can directly present
antigen to these B cells52, and provided stimulation with additional B-cell stimulating
factors occurs, can induce B cell differentiation into IgA+ plasma cells within the lamina
propria50. Lastly, IECs and DCs can directly initiate the class switch recombination from
IgM to IgA by releasing B-cell activating factors, such as BAFF and APRIL, in response
to TLR signaling4,19. Both BAFF and APRIL are recognized by the BAFF receptor and
transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI)
receptor on B cells, which utilize the MyD88-dependent activation of NF-κB to initiate
class switch recombination53.
IgA secreted by plasma cells in the lamina propria must be transported across the
epithelial layer in order to protect the epithelial surface from colonization and invasion by
pathogenic bacteria. This transport process is mediated by the polymeric
immunoglobulin receptor (pIgR)44 (Figure 1-6). pIgR is a mucosal epithelial specific
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protein that is synthesized as an integral membrane protein and is targeted to the
basolateral side of the epithelial cell. At the basolateral surface, pIgR can bind dimeric
IgA secreted by IgA+ plasma cells in the lamina propria. pIgR and bound IgA is then
endocytosed and transported to the apical side of the epithelial cell. At the apical side,
non-specific proteolytic cleavage of pIgR occurs, resulting in the release of the secretory
component (SC) of pIgR bound to IgA. This complex is known as SIgA. This transport
process provides multiple levels of immune protection (Figure 1-7): pIgR has been
shown to excrete potentially harmful IgA-containing immune complexes from the lamina
propria into the lumen54. Transcytosis of SIgA has been shown to neutralize viruses and
microbial products within IECs55. At the apical surface, release of SIgA and SC, both of
which have mucus-binding properties that facilitate the trapping of bacteria within the
mucus layer, enhances epithelial barrier function and limits bacterial adherence and
translocation44,46,56. In the absence of dimeric IgA, constitutive transcytosis and cleavage
still occurs, releasing free SC into mucosal secretions46. Free SC has been shown to
contribute to innate immunity by acting as a non-specific bacterial scavenger and limiting
inflammatory immune response54. pIgR deficient mice display reduced levels of IgA in
mucosal secretions and elevated levels of serum IgA57. Moreover, while IgA deficient
and pIgR deficient mice are more susceptible to experimental colitis, as compared to
wild-type mice, pIgR deficient mice develop more severe intestinal inflammation than
IgA deficient mice, indicating a protective role for SIgA and SC in intestinal
inflammation58.
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Regulation of pIgR Expression and Transport of SIgA
One molecule of pIgR is consumed for every molecule of SIgA transported into
the lumen, thus the rate of pIgR transcription controls the rate of SIgA transcytosis and
high expression of pIgR is required to maintain sufficient supply of SIgA and SC44,46.
Accordingly, steady-state levels of pIgR mRNA in mouse and human IECs are very high.
pIgR expression has been shown to be regulated in vitro by a range of factors, including
cytokines, hormones, dietary factors, microbial factors and viral factors59 (Table 1-1).
Our lab has shown that expression of pIgR is much higher in the colon than in the ileum
of both healthy controls and Crohn’s disease (CD) patients, which is likely due to
enhanced bacterial stimulation of IECs due to greater numbers of commensal bacteria60.
A direct role for commensal bacteria in inducing pIgR expression in vivo was first
suggested by demonstrating that germ-free mice monocolonized with the bacterium
Bacteroides thetaiotamicron resulted in upregulation of pIgR expression61. Importantly,
our lab has recently shown that pIgR expression in the colonic mucosa and IgA levels in
colonic mucus were reduced in MyD88 deficient mice, suggesting that TLR-dependent
MyD88 signaling may also regulate pIgR expression and IgA transport in vivo62.
However, in that study it was not determined whether pIgR was regulated directly by
MyD88 signaling in IECs or indirectly by immune cells in the intestinal lamina propria.
The work presented here investigates the hypothesis that cross-talk between the
commensal microbiota and IECs has a central role in the induction of pIgR expression
and the maintenance of intestinal homeostasis.
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When Intestinal Epithelial Fences and Defenses Fail- Intestinal Inflammation
Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and
Ulcerative colitis (UC), are relapsing, chronic inflammatory diseases of the intestine.
Although the causes of these diseases remain incompletely understood, IBD is thought to
result from inappropriate inflammatory responses to normal components of the intestinal
microbiota in genetically susceptible individuals17. The adaptive immune system, in
particular a heightened effector T cell response, has traditionally been the focus of
investigations into the pathogenesis of IBD63. However, numerous recent reports have
demonstrated that a defective innate immune response within the intestinal mucosa is a
primary contributor 64-68. In particular, dysfunction of the intestinal epithelium has been
shown to be a dominant pathway in IBD65. Genetic defects, as well as experimentallyinduced damage, restricted to the epithelium can initiate and promote intestinal
inflammation in the presence of healthy underlying immunity 34. Thus given their
anatomical and functional position, IECs are central to the process of intestinal
homeostasis. IEC regulate innate immune responses by controlling bacterial-epithelial
interactions, as well as regulate adaptive immune responses by controlling epitheliallamina propria immune cell cross-talk 65.
Defective epithelial barriers or dysregulation of these epithelial defenses have
been shown to lead to a breakdown in intestinal homeostasis and contribute to intestinal
inflammation69. There are several lines of evidence that support the idea that epithelial
permeability defects precede the onset of intestinal inflammation5,69. IBD patients have
an increase in intestinal paracellular permeability and defects in the regulation of tight
junctions70. Mice with a constitutively active myosin light chain kinase (MLCK)
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transgene display increased permeability that is quantitatively and qualitatively similar to
individuals who are high risk for developing IBD69. Furthermore, this defect in tight
junction permeability is shown to be sufficient to accelerate the onset and enhance the
severity of intestinal inflammation71. However, the presence of inflammation has also
been indicated as a cause of epithelial barrier dysfunction, creating a vicious cycle for the
aggravation and perpetuation of inflammation3,17.
Many TLR genetic variants have been associated with human IBD phenotypes
and susceptibility. Polymorphisms in TLR1, TLR2 and TLR9, resulting in dysfunctional
epithelial TLR signaling, are associated with increased risk of developing colitis and
more severe disease72,73. TLR4 variants that result in hyporesponsive LPS-induced TLR
signaling are associated with more severe CD phenotype 74,75. Mice deficient in
individual TLRs that recognize bacterial components, including TLR2, TLR4, TLR5, and
TLR9, as well as MyD88-deficient mice, are more susceptible to DSS colitis6,76-79.
Deletion of TLR5 alone results in the development of spontaneous colitis80. Furthermore,
cell type-specific deletions and bone marrow chimera studies have demonstrated that
epithelial-specific TLR signaling has a protective role against the development of and
response to intestinal inflammation32,42,43,79,81,82. Notably, epithelial deletion of the
downstream NF-κB regulatory component NEMO caused severe spontaneous colitis in
mice34. Alternatively, there is evidence to suggest that hyperactivation of epithelial TLR
signaling is associated with disease. Epithelial-specific deletion of the single
immunoglobulin IL-1 receptor-related molecule (SIGIRR), a negative regulator of
MyD88-dependent TLR signaling, was shown to increase susceptibility of mice to DSS
colitis, characterized by constitutive upregulation of pro-inflammatory genes82. In
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humans, TLR4 expression is upregulated in primary epithelial cells from CD and UC
patients with active disease, indicating a state of TLR hyperactivation83. Hyperactivity to
flagellins, a TLR5 ligand, is observed in sera from patients with CD84,85. Taken together,
these studies suggest that regulated bacteria-epithelial cell cross-talk is essential for
maintenance of intestinal homeostasis and prevention of intestinal inflammation.
The mucus layer has a crucial role in maintaining intestinal homeostasis and a
breakdown in mucus-related defenses are associated with intestinal inflammation. Loss
of goblet cells, resulting in reduced mucin secretion, is a hallmark of IBD1,79.
Additionally, Muc2-deficient mice, which lack a defined mucus layer, develop severe
spontaneous colitis37,38. Several studies have suggested that impaired Paneth cell
development and function and defective IEC secretion of AMPs, in particular αdefensins, may contribute to CD susceptibility86,87.
Our lab has recently revealed that reduced expression of pIgR and dysregulated
transport of SIgA in the colonic mucosa is commonly observed in CD patients60.
Additionally, reduced pIgR expression in a subset of CD patients resulted in
accumulation of IgA deposits in the lamina propria. It is likely that this accumulation of
IgA in the lamina propria could leak into systemic circulation, resulting in the elevated
serum concentrations of IgA observed in these patients as well as pIgR-deficient mice60.
Thus, reduction of pIgR expression during colitis would be predicted to diminish not only
the antimicrobial function of luminal SIgA, but also the removal of IgA-bound antigens
from the lamina propria. These defects would exacerbate local inflammation and
increase the level of IgA immune complexes, a potential risk factor for development of
IgA nephropathy, which has been linked with IBD88. IgA deficiency, independent of
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pIgR expression, is estimated to be 10 times more frequent among patients with intestinal
diseases than in the general public, and it has been proposed that dysregulation of IgA
responses to commensal bacteria results in excessive innate pro-inflammatory responses,
propagating intestinal inflammation19. Mice deficient in either pIgR or IgA are more
susceptible to DSS induced colitis58.
IBD is a significant and growing health problem in the U.S., resulting in four
million prescriptions, over 200,000 hospitalizations, and approximately 1,000 annual
deaths. Although progress has been made in the treatment of IBD, many therapeutic
options include general immunosuppressants and immunomodulatory agents that hardly
address the diversity of colonic inflammatory phenotypes. These biological drugs block
key molecules that are involved in the induction and maintenance of inflammation in
several signaling pathways, all of which have different contributions in different patients
89

. Therefore considering the complex nature and the heterogeneous clinical presentation

of IBD, the need to identify molecular biomarkers that can predict disease behavior is
critical for personalized therapy and effective clinical management of disease.
Significant attempts have been made to identify genetic markers of IBD. The information
that is available include several categories of potential biomarkers, including mucosal
cytokines and chemokines, adhesion molecules, activation markers, serological markers,
as well as immune and non immune cell subsets 89-93. Considering the culminating
evidence that IECs are central to the maintenance of intestinal homeostasis and intestinal
epithelium dysfunction is associated with IBD pathogenesis, potential IEC biomarkers
are continually being investigated. Various studies have shown that IECs inappropriately
express the class II antigen HLA-DR, as well as the co-stimulatory molecule B7 in
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actively inflamed mucosa of IBD patients 94,95. Down-regulation of TLR3 and defensin
expression and upregulation of TLR4 expression was found in active CD patients83,96,97.
However, since IBD is clearly a multifactorial disease that results in a range of
inflammatory phenotypes, multifactorial approaches are being utilized to investigate
potential IBD biomarkers. Accordingly, Arsenescu et al. recently identified signature
mRNA biomarkers in IECs from CD patients that were predictive of clinical
characteristics and responses to therapy60. These studies analyzing human IBD patients
are essential for identifying clinical phenotypes and have potential to significantly
advance diagnostics. However, due to the limitations associated with working with
patients, many of these studies do not, or cannot, investigate the underlying mechanisms
of disease. By understanding the association between the expression of potential
biomarkers with mechanisms of intestinal inflammation and disease severity, it may be
possible to evaluate and tailor therapeutic options to address the patient’s specific disease
course.

Summary and Significance
Intestinal epithelial cells have the unique and complex job of maintaining physical
barriers and immunological defenses in order to not only maintain a symbiotic
relationship with their microbial neighbors, but to prevent these neighbors from causing
serious harm in the rest of the host’s intestinal and systemic neighborhood (Figure 1-8).
The overall aim of this work is to investigate the hypothesis that IECs are central
regulators of intestinal homeostasis and inflammation. By using a multifactorial
approach to analyze epithelial gene expression during experimental colitis, patterns of
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epithelial biomarkers were identified that define underlying mechanisms of inflammation
and are predictive of disease severity. Importantly, this study revealed that the
downregulation of pIgR expression and altered transport of IgA are common features in
human IBD as well as mouse models of experimental colitis, suggesting that maintaining
pIgR expression is required for intestinal homeostasis. These results led to the
investigation into the regulation of pIgR expression by colonic bacteria. By performing a
series of in vitro experiments utilizing inhibitors and siRNAs targeted against specific
components of innate immune signaling pathways in IECs, the MyD88-dependent
activation of NF-κB was identified to be a major regulator of pIgR induction by
commensal bacteria. To determine whether this regulatory mechanism was functional in
vivo, a novel mouse model employing an epithelial-specific deletion of the Myd88 gene
was generated. Loss of MyD88 signaling in IECs caused significantly reduced
expression of pIgR, leading to impaired SIgA transport; reduced expression of Muc-2,
leading to altered mucus production; and reduced expression of AMPs, leading to
defective mucus-associated antimicrobial activity. Taken together, these results suggest a
model in which MyD88-dependent bacterial-epithelial cell cross-talk is crucial for
maintenance of physical and immunological barrier function in the intestine.
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Figure 1-1 Intestinal epithelial cell lineages and the formation of the crypt-villus
axis. The intestinal epithelium consists of four major cell lineages that arise from a
pluripotent stem cell progenitor located in the epithelial crypt region. These include
absorptive enterocytes, which make-up the majority of intestinal epithelial cells (IECs),
the mucus-producing goblet cells, enteroendocrine cells, which are specialized hormoneproducing endocrine cells in the gastrointestinal tract, and Paneth cells, which are the
main producers of antimicrobial peptides. Intestinal stem cells differentiate into
enterocytes, enteroendocrine cells, or goblet cells and migrate upward to the top of the
villi where cellular apoptosis and epithelial shedding occurs. Intestinal epithelial stem
cells can also differentiate into Paneth cells that migrate downward to the bottoms of the
crypts. (Adapted with permission from Yu et al.WJGP 2012)
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Figure 1-2 Overview of the structure of the intestinal immune system. The intestinal
epithelium separates the commensal bacteria in the lumen from the immune cells of the
lamina propria. A mucus layer containing secreted antimicrobial peptides, SIgA and free
secretory component (SC) reinforces the physical epithelial barrier. Below the
epithelium, the lamina propria contains myofibroblasts, B cells, T cells, dendritic cells
(DCs) and macrophages. Specialized lymphoid structures, including Peyer’s patches,
allow for sampling of luminal contents. Antigen-loaded DCs can travel via the
lymphatics to the mesenteric lymph nodes where they can induce B-cell differentiation
into IgA-secreting plasma cells. (Adapted with permission from Abreu et al. Nat. Rev.
Immuno. 2010)
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Figure 1-3 Toll-like receptors (TLR), PAMPs, and Adaptor proteins. All TLRs that
predominantly recognize bacterial components utilize the adaptor protein MyD88. TLR4
is unique in its ability to signal through MyD88 and Trif. (Adapted with permission from
Kawai and Akira, Cell Death and Differentiation (2006) 13, 816–825)
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Figure 1-4. TLR4 signaling pathway. LPS binds to the TLR4 complex on the apical
surface of IEC, initiating MyD88-dependent (blue) and MyD88-independent (yellow)
signaling pathways. Both MyD88-dependent and independent signaling pathways can
lead to the activation of NF-κB and MAPK, resulting in the transcription of inflammatory
cytokines. (Adapted with permission from Gribar et al. Mol. Med. 2008)
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Figure 1-5 Production of IgA specific for intestinal bacteria. 1) Dendritic cells (DC)
in the Peyer’s Patches (PP) and lymphoid follicles capture bacteria internalized by M
cells and migrate to the interfollicular region of the PP or mesenteric lymph nodes (MLN)
where they present antigen to CD4+ T cells. Antigen-activated T cells can induce B cells
to differentiate into IgA+ plasma cells that home to the lamina propria and secrete
dimeric IgA. 2) Lamina propria DCs can directly present antigen to these B cells, and
when provided with additional B-cell stimulating factors, can induce B cell
24

differentiation into IgA+ plasma cells within the lamina propria. 3) IECs can deliver IgAinducing signals to lamina propria B cells by releasing B-cell activating factors in
response to TLR signaling. (Adapted with permission from Hooper et al. Nat. Rev.
Immunol. 10(3):159-69 2010)
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Figure 1-6 pIgR mediated transcytosis of IgA. The polymeric-Ig receptor (pIgR) is
synthesized by IECs and targeted to the basolateral side of the epithelial cell. Dimeric
IgA secreted by plasma cells in the lamina propria is bound by pIgR on the basolateral
side. This complex is transported via receptor-mediated endocytosis to the apical side of
the epithelial cell. Here the receptor is cleaved to leave the extracellular secretory
component (SC) of pIgR bound to IgA. This complex, known as SIgA, binds to mucus
while the nonfunctional residual component of pIgR is degraded (not shown). (Adapted
from Janeway et al.Immunobiology: the immune system in health and disease. Third
Edition. New York: Garland Sciences; 2001)
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Figure 1-7 Mucosal immune defenses mediated by pIgR and SIgA. The pIgR
mediated transcytosis of IgA provides several levels of immune protections. 1) Dimeric
IgA in the lamina propria binds to and excretes antigen back into the lumen via pIgRmediated transcytosis across IEC. 2) polymeric IgA bound to pIgR can inhibit
intracellular virus production and neutralize pro-inflammatory antigens and factors. 3)
SIgA released in to the intestinal lumen binds and neutralizes bacteria and bacterial
products, preventing adhesion to and penetration of the epithelium. 4) Free secretory
component (SC) acts as a non-specific scavenger, neutralizing potential pro-inflammatory
antigens.
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Table 1-1 Regulation of pIgR expression in the intestine.
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Figure 1-8 Colonic epithelial immune defenses. A single layer of intestinal epithelial
cells, joined together by tight junction (TJ) complexes, creates a physical barrier between
the intestinal microbiota and the lamina propria. To reinforce this physical barrier, IECs
also create an immunological barrier. Goblet cells secrete mucin proteins that complex to
create a well organized mucus layer. IECs secrete antimicrobial peptides that are retained
in the mucus layer. Additionally, IgA secreted by plasma cells in the lamina propria is
transported by pIgR across the epithelium. SIgA and free secretory component (SC) are
released into the mucus layer where they can bind bacteria and bacterial products.
(Adapted with permission from Hooper et al. Nat. Rev. Immunol. 2010)
Copyright © Aubrey L. Frantz
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Chapter Two: Materials and Methods

Animals
Six-week old female wild-type C57BL/6 and 8-week old female Rag1-/- C57BL/6
mice were purchased from the Jackson Laboratories (Bar Harbor, ME). Mouse strains
used in the generation of MyD88∆IEC mice were on the C57BL/6 background and
purchased from Jackson Laboratories (Bar Harbor, ME). Mice of the B6.129P2MyD88tm1Defr/J strain were intercrossed to generate mice homozygous for loxP-flanked
Myd88 (MyD88Flox). The B6.SJL-Tg (Vil-cre) 997Gum/J strain, which is transgenic for
Cre recombinase under control of the intestinal epithelial-specific mouse Vil1 gene, was
intercrossed with MyD88Flox mice to generate mice with a targeted deletion of the Myd88
gene in epithelial cells in the small and large bowel (MyD88∆IEC). Experiments were
conducted with littermates generated by crossing MyD88∆IEC mice hemizygous for the
Vil1-Cre transgene with MyD88Flox mice. All mice were housed in microisolator cages
with sterile bedding, food and water in AAALAC-accredited facility. All procedures
were conducted in accordance with guidelines set forth by the University of Kentucky
Institutional Animal Care and Use Committee.

DSS Model of Acute Colitis
Acute colitis was induced by oral administration of dextran sulfate sodium (DSS),
as described98. DSS (molecular weight 36,000 –50,000; MP Biomedicals, Aurora, OH)
was dissolved in water at indicated concentration and given ad libitum to mice for 8 days
in place of normal drinking water. Water intake was measured daily to ensure consistency
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in DSS intake among mice. A disease activity index (DAI) was calculated daily for each
mouse during DSS treatment, on a 0-4 scale that assessed weight loss, stool consistency,
and fecal blood (visible and occult). Weight loss scores were determined as 0 = no weight
loss, 1 = 1–5% weight loss, 2 = 6–10% weight loss, 3 = 11 -15% weight loss, and 4≥15%
weight loss. Stool scores were determined as 0 = normal stools, 2 = loose stools, 4 =
diarrhea. Bleeding scores were determined as 0 = no bleeding, 1 = positive guaiac occult
blood test (minimal color change to green), 2 = positive guaiac occult blood test
(maximal color change to blue), 3 = blood visibly present in the stool, no clotting on the
anus, and 4 = gross bleeding from the anus with clotting present. ColoScreen-ES testing
kits (Helena Laboratories, Beaumont, TX) were used to detect occult blood. ColoScreenES testing kits (Helena Laboratories, Beaumont, TX) were used to detect occult blood.

T cell Transfer Model of Chronic Colitis
Chronic colitis was induced by adoptive transfer of naïve T cells from wild-type
mice into Rag1-/- recipients, which lack B and T lymphocytes, as described99. To purify
T-effector (Teff) and T-regulatory (Treg) cell populations for adoptive transfer, single
cell suspensions from spleens of 10 week-old wild-type C57BL/6 mice were prepared in
phosphate-buffered saline with 4% fetal bovine serum. In two of the three independent
experiments, CD4+CD45RBhi and CD4+CD45RBlo cell populations were isolated by
fluorescence-activated cell sorting. Spleen cells were labeled with anti-CD4 antibodies
(eBiosciences, San Diego CA) and anti-CD45RB (Biolegend, San Diego CA) and sorted
into CD4+CD45RBhi (as a source of Teff) and CD4+CD45RBlo fractions (as a source of
natural Treg), defined as the uppermost 30% of cells with the brightest CD45RB staining
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and the lowest 15% of cells with the dimmest CD45RB expression, respectively (Figure
3-1A, left panel). The Teff and Treg fractions were subsequently demonstrated to differ
dramatically in cell surface expression of CD25, a marker for natural Treg (Figure 3-1A,
right panel). In one of the three independent experiments, CD4+ splenic T cells were
separated into CD25- (Teff) and CD25+ (Treg) populations by magnetic bead sorting
using the Regulatory T cells kit (Miltenyi, Auburn CA). Nine-week-old Rag1-/- C57BL/6
mice received a single intraperitoneal injection of 4 x 105 purified Teff, with or without 1
x 105 purified Treg. Following adoptive transfer, body weight was monitored every 3
days and mice were sacrificed at 10 weeks post-transfer. No significant differences were
observed in clinical parameters, tissue histology or colonic EC gene expression that could
be attributed to the different methods of purification of Teff and Treg populations
(immunofluorescence vs. magnetic beads).

Tissue Histology
Colons were dissected from euthanized mice and the length of the colon from the
anus to the cecal junction was measured. For T cell transfer colitis, colons were weighed
and the weight/length ratio was calculated. Colons were cut lengthwise, and half of each
colon was prepared in a “Swiss roll”100 and fixed in 10% buffered formalin (Fisher
Scientific, Fair Lawn, NJ). Fixed tissues were embedded in paraffin, sectioned, stained
with hematoxylin and eosin, and evaluated in a blinded fashion for evidence of
inflammation and epithelial damage. Tissue damage for DSS colitis was quantified on a
scale from 0–4 as previously described98, using the following criteria: 0, no change from
normal tissue; grade 1, mild inflammation present in the mucosa, comprised mainly of
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mononuclear cells, with little epithelial damage; grade 2, multifocal inflammation greater
than a grade 1 score, including mononuclear cells and some neutrophils, detachment of
crypt glands from the muscularis mucosae, mucin depletion from goblet cells, and
occasional detachment of the epithelium from the mucosa; grade 3, multifocal
inflammation greater than a grade 2 score, including mononuclear cells and neutrophils
infiltrating the submucosa, crypt abscesses present with increased mucin depletion, and
significant epithelial disruption, including some ulceration; grade 4, crypts no longer
present, severe mucosal inflammation mainly composed of neutrophils, and epithelium
no longer present or completely detached. An average of 4 fields of view per colon were
evaluated for each mouse to obtain a composite score. For T cell transfer colitis, a total
histopathological score was calculated by combining the scores for each of the seven
following parameters for a maximum score of 17: degree of inflammation in the lamina
propria (score 0-3), goblet cell loss (score 0-3), abnormal crypts (score 0-3), presence of
crypt abscesses (score 0-1), mucosal erosion and ulceration (score 0-1), submucosal
spread to transmural involvement (score 0-3), and number of neutrophils counted at 40x
magnification (score 0-3).

Colonic Epithelial Cell Isolation
CEC were isolated as previously described 101. Colons were opened
longitudinally, cut into 1 mm pieces, and the mucus layer was removed by incubation for
20 min with agitation at 37°C in a solution of 1mM dithiothreitol (Sigma, St. Louis MO)
in DMEM:Ham’s F-12 (1:1) tissue culture medium (Lonza, Walkersville MD),
supplemented with 5% fetal bovine serum and antibiotics (100 U/ml penicillin, 100
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µg/ml streptomycin, and 250 ng/ml fungizone) (Invitrogen Life Technologies, Carlsbad
CA). The supernatants were discarded, and CEC were stripped from the colon pieces by
incubation for 1 h at 37°C in a solution of 0.5 M EDTA in supplemented tissue culture
media. The suspension was vortexed vigorously, and the remaining colon fragments were
allowed to settle at the bottom of the flask. The upper layers were centrifuged at 2000
rpm for 10 minutes at 4°C to collect ECs. Further purification of the CEC fraction was
accomplished by resuspension of the cell pellets in a 10 ml solution of 30% w/v Percoll
(Sigma) and centrifugation at 1300 rpm for 20 min at room temperature. The top layer
containing floating CEC was removed and transferred into a 15 ml conical tube. The
volume was brought to 10 ml with supplemented tissue culture medium, and the CEC
solution was pelleted by centrifugation at 2000 rpm for 10 min at 4°C. CEC viability,
assessed by trypan blue exclusion, was typically > 90 %. Flow cytometry analysis of
representative CEC preparations indicated that contamination with CD45+ hematopoietic
cells was approximately 0.4 % for control mice and 1.3 % for DSS-treated mice (Figure
3-1B).

Analysis of mRNA Levels by Real-time PCR and Nanostring nCounterTM
Hybridization
mRNA levels for individual genes were analyzed by quantitative reverse
transcriptase-polymerase chain reaction (qRT-PCR) as previously described102. Total
RNA was purified from isolated CEC using the Qiagen RNeasy Protect mini kit (Qiagen,
Germantown MD). RNA was reverse-transcribed to generate cDNA templates using the
TaqMan Gold RT-PCR kit (Applied Biosystems, Foster City, CA). Specific mRNA
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levels were quantified by quantitative real-time polymerase chain reaction, using the ABI
Prism 7700 Sequence Detection System (Applied Biosystems) as previously described102.
The level of β2-microglobulin mRNA, which we found did not vary with experimental
treatments, was used to normalize mRNA for tested genes according to the following
formula: (2-(C T test – C T β2-microglobulin)) x 100%. For mRNA analysis using the Nanostring
nCounterTM hybridization technique, colonic epithelial cells were isolated from freshly
dissected colons as previously described101. Abundance of mRNA transcripts was
analyzed by Nanostring nCounterTM hybridization103, and normalized using an algorithm
developed by NanoString, Technologies (Seattle, WA).

Immunofluorescence Microscopy
Sections of formalin-fixed, paraffin-embedded colon tissues were dewaxed and
rehydrated using standard protocols. Antigen retrieval was performed by incubating
slides for 20 min at 95°C in 25 ml of 10 mM sodium citrate buffer, pH 6. Endogenous
peroxidase activity was quenched by incubation for 10 min at room temperature in 25 ml
of 3% (v/v) H 2 0 2 . Cell-associated pIgR and free secretory component (the cleaved
extracellular domain of pIgR) were detected by overnight incubation of tissue sections at
4°C with a polyclonal goat antibody to mouse secretory component (2.5 µg/ml) (R&D
Systems, Minneapolis, MN). Sections were washed with PBS and incubated for 30 min at
room temperature with a horseradish peroxidase-conjugated rabbit antibody to goat IgG
(1µg/ml) (Invitrogen, Camarillo CA). Bound peroxidase was revealed with TSA PlusTMR Reagent (Perkin-Elmer, Waltham MA). IgA was detected in the same tissue
sections by subsequent incubation for 1 hour at room temperature with FITC-conjugated
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antibody to mouse IgA (1µg/ml) (eBiosciences, San Diego CA). MyD88 was detected
with a rabbit antibody (Abcam, Cambridge, MA) followed by horseradish peroxidaseconjugated antibody to rabbit IgG (Invitrogen, Camarillo CA) and TSA Plus-TMR
Reagent (Perkin-Elmer, Waltham MA). All antibodies were diluted in Blocking Reagent
(Perkin-Elmer). Sections were mounted with VectaShield (Vector Laboratories,
Burlingame CA) containing DAPI to visualize nuclei. Stained tissue sections were
imaged on a Zeiss Axiophot confocal microscope (Carl Zeiss Microscopy LLC,
Thornwood, NY) with Axiovision image software.

Statistical Analysis
Statistical differences in disease parameters mRNA levels, CFU, and disease
activity were determined by analysis of variance and Fisher’s protected least significant
difference test. Correlation Z test was used to test for correlations among mRNA levels
for different biomarkers. Factor analysis was used to reduce the 5 mRNA biomarkers into
two principal components (PCs), as previously described 104. To assign scores for PC1
and PC2, the mRNA level for each of the five biomarkers for each mouse was first
normalized to the mean for that biomarker for all mice within the DSS protocol or the T
cell transfer protocol. Individual scores for PC1 and PC2 were calculated as the sum of
the normalized value for each biomarker multiplied by the weight for that biomarker.
Linear regression analysis was used to compare PC1 or PC2 values with % initial weight,
colon length or the ratio of colon weight/length, and histological score. For MyD88∆IEC
and MyD88Flox mice with or without DSS treatment, nineteen genes from a total of 36
were selected for PCA, based on ranking of P values for the comparison of mRNA
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transcript levels in MyD88∆IEC and MyD88Flox mice, with and without DSS treatment (n =
31) (see Tables 5-2, 5-3 and 5-4). Factor analysis by the principal component method3
detected a significant relationship among the 19 transcripts (x2 = 816.7, p < 0.0001), and
reduced the data to 4 principal components (PCs) (Figure 5-14). PC1 and PC2 together
accounted for 68.8% of the overall variance in gene expression, whereas PC3 and PC4
only contributed minimally (variance proportion < 0.1). Scores for PC1 and PC2 for each
individual mouse were calculated as the sum of normalized expression levels for each
gene multiplied by the corresponding coefficient for PC1 and PC2.A one-tailed Student’s
t test was used to compare TER values for colon tissues. Permutational multivariate
ANOVA was utilized to compare the fecal microbiota between mouse genotypes, based
on distance matrices of OTUs. All statistical analyses were performed using StatView
Software (SAS Institute, Cary, NC).

Cell Culture
The HT-29v20 subclone of the human colon adenocarcinoma cell line HT-29 was
cultured as described. 14 Where indicated, cells were stimulated with human recombinant
TNF (R & D Systems, Minneapolis, MN) at 10 ng/ml, purified Escherichia coli O26:B6
LPS (Sigma-Aldrich, St Louis, MO) at 1 µg/ml, pIC (Sigma-Aldrich) at 100 µg/ml. The
human acute myeloid leukemia cell line THP-1 (Tsuchiya et al., 1980) (a generous gift of
Dr. Sarah D’Orazio, University of Kentucky) were cultured in DMEM Ham’s F-12 (1:1)
media supplemented with 5% fetal bovine serum and antibiotics (100 U/ml penicillin100
ng/ml fungizone) at 37°C and 5% CO2. All cell culture reagents were from Lonza
Walkersville (Walkersville, MD) or Invitrogen Life Technologies (Carlsbad, CA). THP-1
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cells were maintained in suspension culture, and were diluted to a density of 1 × 106
cells/well in 24-well dishes immediately before stimulation. Additionally, HT-29 and
THP-1 cells were treated with the following TLR ligands at a final concentration of 1
μg/ml: N-palmitoyl-S-[2,3 bis(palmitoyloxy)- propyl]-Cys-Ser-Lys trihydrochloride
(Pam3CSK4) (InvivoGen, San Diego, CA), a synthetic tripalmitoylated lipopeptide that
acts as a ligand for TLR2; or highly purified lipopolysaccharide (LPS) from E. coli
O26:B6 (Sigma-Aldrich, St. Louis, MO), which acts as ligand for TLR4.
To knockdown MyD88, HT-29 cells were transfected with SureSilencingTM
plasmids encoding shRNA specific for human MyD88 or an irrelevant control shRNA
(SABiosciences, Frederick, MD, cat no. KH00911P), and puromycin-resistant subclones
were isolated as described105. For RelA or RelB knockdown experiments, HT-29 cells
were previously transfected with the pSIREN-RetroQ expression plasmid (BD
Biosciences, San Jose, CA) encoding RelA, RelB, or an irrelevant control siRNA,
selected for stable integration of the plasmid by resistance to puromycin, and cloned by
limiting dilution. The sequence of the RelB siRNA was previously reported. 26 The
sequence of the RelA siRNA (5’–3’) was
GATCCGATCAATGGCTACACAGGATTCAAGAGATCCTGTGTAGCCATTGATC
TTTTTTG and the sequence of the control siRNA (5’–3’) was GATCCGCGGGCTG
ATGCTGCACCAATTCAAGAGATTGGTGCAGCATCAGCCCGTTTTTTG.

Bacterial Culture from Mouse Feces and Tissues
Fecal pellets were gently released from dissected colons and homogenized in
PBS. Luminal washes were collected by flushing colons with 5 ml of PBS, and mucus
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was collected by gentle scraping. Aliquots of fecal homogenates, luminal washes and
mucus were cultured for 48 h on LB agar at 37o under anaerobic conditions. For analysis
of bacterial translocation, MLNs were homogenized in PBS and cultured anaerobically
for 48 h. E. coli strain Nissle 1917 (a generous gift of Dr. Ulrich Sonnenborn,
Ardeypharm GmbH, Herdecke, Germany) was transformed to kanamycin resistance, and
KanR E. coli were delivered to the mice in the drinking water at a dose of 2.5 x 107
CFU/ml for 7 days. Feces, luminal washes and colonic mucus were collected as described
above and cultured anaerobically in 50 µg/ml kanamycin to enumerate CFU.

Measurement of Transmucosal Electrical Resistance (TER)
Segments of mouse colon were mounted in 0.3 cm2 aperture Ussing chambers
(Physiologic Instruments, San Diego, CA), and TER was measured as previously
described106. Apical and basolateral recording buffers contained 118 mM NaCl, 5 mM
KCl, 2 mM NaH 2 PO 4 , 1.2 mMMgSO 4 , 1 mM CaCl 2 , 10mM HEPES, 10mM glucose,
and 22 mM NaHCO 3 , pH 7.4, and were bubbled with 95% O 2 and 5% CO 2 at 37 °C.

Analysis of Mucus-Associated Antimicrobial Activity
Colonic mucus was isolated as described above, diluted 1:3 in PBS, and
concentrated by centrifugation at 2500 rpm for 10 min. 106 CFU of KanR E. coli from a
mid-log phase culture was added to the mucus, then centrifuged together at 1500 rpm for
15 min at room temperature. Serial dilutions of bacterial suspensions before and after
incubation with colonic mucus were cultured anaerobically for 24 h in 50 µg/ml
kanamycin to enumerate CFU.
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Bacterial Invasion Assays
Binding and invasion of HT-29 cells was assessed for E. coli (strain Nissle 1917),
Klebsiella pneumoniae (strain isolated from MLNs of MyD88∆IEC mice) and Salmonella
typhimurium (strain SL1344) as described107. Approximately 106 CFU were added to
monolayers of HT-29 cells at an MOI of 10:1. After 2 h at 37o, cell monolayers were
washed and lysed with 1% Triton X-100 to enumerate total cell-associated bacteria.
Parallel co-cultures of bacteria and HT-29 cells were treated with gentamicin (100 μg/ml)
for 90 min to kill extracellular bacteria, washed and cultured to enumerate intracellular
bacteria. Membrane-associated bacteria were calculated by subtracting internalized CFU
from total cell-associated CFU.

Analysis of the Fecal Microbiota
Fecal samples were collected from littermate MyD88Flox and littermate
MyD88∆IEC mice, and frozen samples of fecal DNA (extracted with the QIAamp DNA
stool kit, Qiagen, Germantown, MD) were shipped to Second Genome, Inc. (San Bruno,
CA) for analysis of microbial richness and diversity by the PhyloChipTM microarray
method108 (www.secondgenome.com). Bacterial 16S rRNA genes were amplified by
PCR using the forward primer 5’-AGRGTTTGATCMTGGCTCAG-3’ and reverse
primer 5’-GGTTACCTTGTTACGACTT-3’, fragmented, biotin labeled, and hybridized
to the PhyloChip™ Array, version G3. Stained arrays were scanned with a GeneArray®
scanner (Affymetrix), and analyzed by Affymetrix software (GeneChip® Microarray
Analysis Suite). All profiles are inter-compared in a pair-wise fashion to determine a
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UniFrac distance metric, which utilizes the phylogenetic distance between OTUs to
determine the dissimilarity between communities109. For weighted UniFrac, (WuniFrac),
both the abundance and dissimilarities among OTUs were considered. The phylogenetic
tree shown in (Figure 5-9) was generated using the “Interactive Tree of Life” software
tool110. Based on 14,193 OTUs present in at least one of the mice, a Welch t-test was
performed across the two genotypes using abundance metrics. Principal Component
Analysis (PCA) was used to position points on two-dimensional ordination plots based on
dissimilarity values (Figure 5-10A , left panel). Significant OTUs whose abundance
characterizes each mouse genotype (Figure 5-10A, right panel) were identified by
Prediction Analysis for Microarrays, which utilizes a nearest shrunken centroid
method111.

Analysis of fecal IgA and albumin by ELISA
Freshly collected feces were diluted in 50 mM Tris, pH 7.4, 0.14 M NaCl, 1%
BSA, 0.05% Tween 20, and analyzed by ELISA as previously described11 using mouse
IgA (Cat. No. E90-103) and mouse albumin (Cat. No. E90-134) ELISA Quantification
Sets (Bethyl Laboratories, Montgomery TX).

Quantification of Bacteria by qRT-PCR
Fecal homogenates, luminal washes and mucus were collected as described
above. Bacterial DNA was extracted by column purification using the QIAamp DNA
stool mini kit (Qiagen Cat. No. 51504), and the 16S rRNA gene was amplified by realtime PCR using universal primers as described112. To quantify total numbers of bacteria,
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C T values from individual samples were compared to regression lines of C T values
generated using defined quantities of bacterial DNA from representative species from the
four major phyla of colonic bacteria.

Identification of K. pneumoniae in mesenteric lymph nodes
Mesenteric lymph nodes (MLNs) were dissected under sterile conditions,
homogenized in sterile PBS, and cultured for 48 h on LB agar at 37o under anaerobic
conditions. Approximately 25% of the bacterial colonies had a large, mucoid
morphology. To identify these bacteria, 12 colonies derived from two different
MyD88∆IEC mice were harvested and cultured overnight in LB broth at 37o under
anaerobic conditions. Bacterial DNA was extracted by column purification, and the 16S
rRNA gene was amplified by real-time PCR using universal primers112. The PCR
products were ligated into the pGEM-T vector (Promega, Madison, WI), then used to
transform frozen competent E. coli DH5α (Promega) to ampicillin resistance using
standard protocols. Two ampicillin-resistant colonies were harvested and cultured in LB
broth containing 100µg/ml ampicillin. Bacterial DNA was purified using the Qiagen
miniprep kit (Qiagen, Germantown, MD), and shipped to ACGT, Inc. (Wheeling, IL) for
sequence analysis. Identical sequences of the unknown 16S rRNA gene (which were
identical for the 2 colonies analyzed; Figure 5-4A) were compared with the sequences of
known bacterial genomes by BLAST analysis of the National Center for Biotechnology
Information database (http://blast.ncbi.nlm.nih.gov/Blast). The highest alignment scores
were observed with16S rRNA genes from 5 strains of Klebsiella pneumoniae, and
slightly lower scores were observed with 16SrRNA genes from other species in the
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family Enterobacteriaceae, including Escherichia coli (Figure 5-4B). The original
bacterial colonies cultured from the MLNs of MyD88∆IEC mice were positively identified
as K. pneumoniae by biochemical tests using differentiation media2, including Indole,
Simmons citrate and Christensen’s urea agar, according to the manufacturer’s protocol
(Remel, Lenexa, KS) (Figure 5-4C).

Copyright © Aubrey L. Frantz 2012
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Chapter Three: Multifactorial Patterns of Gene Expression in Colonic Epithelial
Cells Predict Disease Phenotypes in Experimental Colitis

Introduction
Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and
ulcerative colitis (UC), are thought to result from inappropriate inflammatory responses
to normal components of the intestinal microbiota in genetically susceptible
individuals113-115. Recent evidence has implicated both ineffective innate immune
responses and overactive adaptive immune responses in the pathogenesis of IBD6368,113,114,116

. Colonic epithelial cells (CEC) bridge innate and adaptive immune responses

through cross-talk with luminal bacteria and with lamina propria immune cells65,113,114.
There is a critical need to identify cellular and molecular biomarkers that can predict
disease behavior and guide personalized therapy, and a number of candidates have been
proposed89-93. Considering the complex etiology and the heterogeneous clinical
presentation of IBD, we propose that a multifactorial approach offers significant
advantages over the use of single biomarkers for diagnosis and treatment of IBD.
Our group recently identified signature biomarkers in the colonic mucosa of CD
patients that could be used in a multifactorial analysis to classify patients into molecular
phenotypic subsets that were predictive of clinical characteristics and responses to
therapy60. These biomarkers comprised 5 genes: the RelA subunit of NF-κB; A20, an
ubiquitin-modifying enzyme that negatively regulates the NF-κB activation pathway; the
polymeric immunoglobulin receptor (pIgR), which mediates epithelial transcytosis of IgA
antibodies; the pro-inflammatory cytokine tumor necrosis factor (TNF), and the pro-
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inflammatory chemokine interleukin (IL)-8. The aim of the present study was to define
patterns of biomarker gene expression that reflect the underlying mechanism and severity
of intestinal inflammation. To this end we utilized two mouse models of colitis with very
different etiologies. Oral administration of dextran sulfate sodium (DSS) induces acute
colitis that is mediated primarily by effectors of innate immunity and causes damage to
the epithelial barrier117. In contrast, adoptive transfer of naïve T cells into
immunodeficient mice causes chronic colitis initiated by effector T cells and
characterized by epithelial hyperplasia, goblet cell depletion and transmural
inflammation99,118-120. We found different patterns of biomarker expression in these two
models of experimental colitis that were predictive of disease severity. Importantly,
down-regulation of expression and altered cellular localization of pIgR was a common
feature of both colitis models. Furthermore, these defects were associated with failure to
transport IgA. These results provide insights into the functions of CEC in regulation of
intestinal inflammation, and provide proof of principle for the use of principal component
analysis in the molecular diagnosis of intestinal inflammation.

Results
Assessment of disease severity in DSS and T cell-mediated colitis
Acute colitis induced by oral administration of DSS resulted in significant weight
loss, disease activity (diarrhea and blood loss) and pathological findings (colon
shortening), with more severe symptoms in mice administered 3% DSS than 2% DSS
(Figure 3-2 A, B). Tissue damage, including edema, goblet cell loss, ulcerations,
epithelial cell destruction, and infiltration of inflammatory cells, was observed in all
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DSS-treated mice and was more severe in mice treated with 3% DSS (Figure 3-2 C).
Chronic colitis induced by adoptive transfer of CD4+CD45RBhiCD25- Teff cells (Figure
3-1A) into Rag1-/- recipients resulted in a different clinical picture involving weight loss
and an increased ratio of colon weight/length (Figure 3-2 D,E), but no symptoms of
acute colitis such as diarrhea or blood loss (data not shown). Co-administration of
CD4+CD45RBloCD25+ Treg with Teff corrected the clinical symptoms of T cellmediated colitis. Interestingly, colon tissues from control Rag1-/- mice exhibited a
significantly shorter epithelial crypt length than did wild-type mice (compare Figure 3-2
B and 2E) suggesting that the absence of B and T lymphocytes impaired normal
development of the colonic epithelium. Adoptive transfer of Teff, with or without Treg,
resulted in extensive crypt lengthening (Figure 3-2 F). Histological evidence of Teffmediated colitis included infiltration of lymphocytes and mononuclear cells into both the
mucosa and submucosa, but fewer neutrophils. Some mucosal edema and epithelial
damage was observed, but this was less severe than in acute DSS-mediated colitis mice
(compare Figure 3-2 C and F). Co-administration of Treg with Teff resulted in a
moderate reduction in the inflammatory infiltrate and lessened epithelial damage and
mucosal edema.

Differential expression of “signature” biomarkers in colonic epithelial cells in acute
DSS-mediated and chronic T cell-mediated colitis
We used these different models of experimental colitis to examine the relationship
between the etiology of intestinal inflammation and gene expression in colonic ECs.
Flow cytometry analysis of representative CEC preparations indicated that contamination
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with CD45+ hematopoietic cells was on average less than 1% (Figure 3-1B). RNA was
extracted from isolated ECs, and levels of mRNA were analyzed for 5 “signature”
biomarkers that we have used to classify IBD patients into molecular phenotypic subsets
60

, i.e., RelA, A20, pIgR, TNF and MIP-2 (a functional homolog of human IL-8) (Figure

3-3). While the overall patterns of biomarker expression varied considerably between
DSS and T cell-mediated colitis, the one common feature was down-regulation of pIgR
mRNA. Interestingly, co-administration of Treg with Teff prevented down-regulation of
pIgR. These data are consistent with the notion that mucosal inflammation, independent
of its cause, is sufficient to impair normal expression of pIgR. By contrast, downregulation of the RelA subunit of NF-κB was a more consistent feature of T cellmediated colitis than DSS colitis. Down-regulation of RelA in mice adoptively
transferred with Teff was correlated with reduced expression of A20, a RelA target gene
that is induced by the classical NF-κB pathway and acts as a negative feedback regulator
of NF-κB activation 121. Co-administration of Treg with Teff did not restore RelA mRNA
to control levels, but was sufficient to prevent down-regulation of A20. Finally, acute
DSS colitis was characterized by strong up-regulation of the pro-inflammatory genes
TNF and MIP-2 in CEC, which was not seen in chronic T cell-mediated colitis.

Multifactorial patterns of biomarker expression predict disease phenotype
It is clear that synergistic interactions among multiple gene products are involved
in inflammatory responses, thus we used a multifactorial approach to identify patterns of
gene expression that are associated with different etiologies of colitis. Factor analysis by
the principal component (PC) method is a statistical approach that is used to reduce the
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number of variables in a complex data set and to classify relationships between those
variables. We previously used PC analysis, based on the 5 “signature” biomarkers
described in Figure 2, to classify CD patients into molecular phenotypic subsets that were
predictive of clinical disease 60. Here we demonstrate different patterns of gene
expression associated with DSS and T cell-mediated experimental colitis in mice (Figure
3-4). Chi-square analysis indicated that variability in the gene expression data sets for
both DSS colitis and T cell transfer colitis could be reduced to two PCs (p < 0.0001)
(Figure 3-4A). Eigen values indicated that the proportion of variance among mice in
expression of these 5 variables that could be described by PC1 and PC2 together was
72.5% for DSS colitis and 75.1% for T cell transfer colitis. The coefficients for each
variable describe its relative contribution to PC1 and PC2. For both DSS colitis and T cell
transfer colitis, PC1 was strongly weighted toward RelA, A20 and pIgR, with a negative
weight for MIP-2. Interestingly, TNF had a minimal contribution to PC1 for DSS colitis,
but contributed strongly to PC1 for T cell transfer colitis. PC2 was strongly weighted
toward TNF and MIP-2 for both DSS colitis and T cell colitis. The relative contributions
of RelA and A20 to PC2 differed for the two models, and pIgR did not contribute
significantly to PC2 for either model. We conclude that the different patterns of epithelial
gene expression reflect the different etiologies of DSS and T cell-mediated colitis and
may be useful for predicting disease phenotype. To this end, each mouse was assigned a
score for PC1 and PC2 based on the sum of the weighted expression levels for all 5
biomarkers (see Materials and Methods for details) (Figure 3-4B). For the DSS model,
PC1 scores did not vary significantly among treatment groups, whereas the score for PC2
increased significantly with increasing DSS dose. Interestingly, the opposite pattern held
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for T cell transfer colitis. Adoptive transfer with Teff resulted in a significantly lower
PC1 score, which was prevented by co-administration of Treg, whereas no significant
differences in PC2 scores were observed.
To investigate whether these multifactorial PCs could predict disease severity, we
performed linear regression analysis to examine the relationship between PC1 and PC2
scores and clinical measures of disease (Figure 3-5). In the DSS colitis model, increased
PC2 scores were significantly correlated with weight loss, decreased colon length (a
measure of disease severity in DSS colitis),122 and tissue damage (quantified by
histological score). A different pattern was observed for the T cell transfer colitis model,
in which decreased PC1 scores were significantly correlated with weight loss and an
increased ratio of colonic weight/length (a measure of disease severity in T cell transfer
colitis). 99,118 However, tissue damage in this model was significantly correlated with
increased PC2 scores, similar to the pattern seen in DSS-induced colitis. Taken together,
these results suggest that a multifactorial approach combining the expression of multiple
biomarkers in colonic EC can be used to discriminate among different mechanisms of
inflammation and to predict disease severity.

Colonic inflammation results in altered localization of pIgR and reduced epithelial
transcytosis of IgA
We previously reported that expression of pIgR and epithelial transcytosis of IgA
were dysregulated in the colonic mucosa of Crohn’s disease patients60. Because downregulation of pIgR mRNA in CEC was a common feature of both DSS and T cellmediated colitis (Figure 3-3A, B), we hypothesized that epithelial transcytosis of IgA
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would also be altered. Visualization of pIgR and IgA in sections of colonic tissue
revealed reduced expression and aberrant localization of pIgR in the colonic epithelium
in both DSS-induced (Figure 3-6A) and T cell-mediated colitis (Figure 3-6B). In
untreated wild-type mice (Figure 3-6A, left panel), pIgR expression was abundant and
predominantly localized to the lower two-thirds of the epithelial crypts. Significant colocalization of pIgR and IgA was observed, consistent with normal transcytosis of IgA.
However, in the colons of DSS-treated mice, pIgR staining was clearly reduced,
consistent with reduced pIgR mRNA levels (Figure 3-3A), and was not concentrated in
the lower section of the crypts. Importantly, we also observed less co-localization of IgA
and pIgR in DSS-treated mice, although the presence of IgA-producing plasma cells in
the lamina propria was increased. Similar to wild-type mice, pIgR was predominantly
localized to the lower two-thirds of the epithelial crypts in control Rag1-/- mice (Figure
3-6B). No IgA was detected in the colons of these mice, since they lack B cells and
cannot produce IgA. Total pIgR staining was markedly reduced in the Rag1-/- mice
adoptively transferred with Teff, consistent with down-regulation of pIgR mRNA
(Figure 3-3B), and concentration of pIgR in the lower section of the crypts was not seen.
Expression of pIgR was substantially restored when Treg cells were co-transferred with
Teff (Figure 3-6B), consistent with the restoration of pIgR mRNA levels (Figure 3-3B).
However, concentration of pIgR localization in the lower section of the crypts was not
fully restored.
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Discussion
Molecular classification of IBD patients based on multifactorial patterns of
biomarker expression offers the potential to personalize diagnosis and clinical
management of this chronic and debilitating disease. Experimental mouse models of IBD
have proven to be valuable tools for investigating mechanisms of IBD pathogenesis and
for identifying potential therapeutic targets117,123. Oral administration of DSS causes
concentration- and time-dependent cytotoxicity of intestinal epithelial cells, thus
disrupting intestinal barrier function124. Because acute colitis could be induced by DSS in
mice with severe combined immunodeficiency, which lack B and T lymphocytes125, it
has long been thought that intestinal inflammation in this model is driven mainly by
innate immune responses. However, more recent studies comparing DSS-induced colitis
in immunodeficient and wild-type mice suggested that the presence of lymphocytes may
exacerbate inflammation, particularly at low doses of DSS126. In the T cell transfer
model, chronic colitis develops as a result of enteric antigen-driven activation,
polarization and homeostatic expansion of naïve T cells to produce colitogenic Th1
and/or Th17 effectors cells117, 118. Co-administration of T regulatory cells with T effector
cells prevents induction of colitis, verifying a significant protective role for T regulatory
cells in IBD pathogenesis99,127.
Here we have focused on a limited set of 5 “signature” epithelial biomarkers that
we previously validated for prediction of disease severity in CD patients60. Given the
heterogeneous clinical presentation in IBD, it is likely that a classification scheme based
on multiple biomarkers will be more informative than the use of individual biomarkers. It
is clear that the expression of many genes may change during intestinal inflammation.
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However, by focusing on only 5 highly informative genes, we have provided proof of
principle that a multifactorial approach can transform a limited amount of data into a
potentially powerful diagnostic tool. We have now identified distinctive expression
patterns of these 5 biomarkers expression in two models of experimental colitis with
different etiologies (Figure 3-3). Principal component analysis reduced the 5 biomarkers
into 2 multifactorial PCs that were specific for each model (Figure 3-4) and were
predictive of disease severity (Figure 3-5). We propose that PC1 is a composite
biomarker reflecting homeostatic epithelial barrier function, characterized by NF-κBstimulated physiological inflammation. The individual biomarkers RelA, A20 and pIgR
were dominant contributors to PC1 in both colitis models. We previously reported that
high expression of PC1 was associated with mild disease activity and good responses to
therapy in CD patients60. We found that high expression of pIgR was correlated with
robust epithelial transcytosis of IgA. While excessive NF-κB signaling in immune cells
has been implicated as a major contributor to intestinal inflammation and the
development of IBD, NF-κB signaling in epithelial cells has been shown to promote
intestinal homeostasis128-130. Our finding of a potential protective role for NF-κB
signaling is consistent with the report of Eckmann et al.33 in which ablation of the NFκB-activating kinase IKKβ in intestinal epithelial cells resulted in an exacerbation of
DSS-induced colitis. However, these investigators found that loss of epithelial IKKβ had
no impact on chronic colitis that occurs spontaneously in IL-10-deficient mice. Thus the
protective functions of epithelial-specific NF-κB signaling likely depend on specific
etiology of intestinal inflammation. We found that epithelial expression of the proinflammatory genes TNF and IL-8 (or mouse MIP-2, a functional homolog of human IL52

8) contributed strongly to PC2. While a normal range of PC2 values is consistent with
NF-κB-stimulated physiological inflammation, high PC2 values may indicate an
excessive and damaging inflammatory response. Here we found that disease severity in
acute DSS colitis was correlated with elevated PC2 values, with no significant alterations
in PC1 values. These results are consistent with our previous findings in CD patients,
where a subset of recently-diagnosed patients with elevated PC2 values and variable PC1
values tended to present with acute inflammation that responded well to
immunosuppressive and anti-TNF therapy60. In a recent analysis of these biomarkers in
colonic biopsies of patients with UC, we observed a similar correlation between elevated
PC2 values and acute inflammation (Bruno et al., unpublished data). These findings are
significant in that many features of DSS colitis, such as macroscopic appearance and
histological injury, more closely resemble acute inflammation in UC than CD131. In
contrast, we found that some measures of disease severity in chronic T cell-mediated
colitis (weight loss, colon weight/length ratio) were correlated with low PC1 values,
whereas tissue damage in the colon was associated with high PC2 values. This pattern is
similar to that observed in subsets of CD and UC patients with low PC1 and variable PC2
values, characterized by chronic inflammation and poor responses to immunosuppressive
and anti-TNF therapy 60(Bruno et al., unpublished data) . The results of our current study
suggest that acute colitis mediated by innate immune responses is associated with
increased epithelial expression of pro-inflammatory genes, whereas chronic colitis driven
by adaptive T cell responses is associated with diminished expression of genes associated
with homeostatic epithelial barrier function. These findings provide insights into the role
of epithelial cells in the regulation of colonic inflammation, and support the use of these
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epithelial biomarkers for monitoring disease course and guiding therapy in IBD patients.
We propose that multifactorial analysis of CEC gene expression may be valuable for
monitoring the transition from acute to chronic colitis in IBD patients. This approach may
enhance our understanding of immunological mechanisms underlying inflammation at
different stages, which may require different therapeutic approaches, and may also help
to identify patients at risk for sequelae associated with chronic inflammation, such as
colitis-associated cancer.
A novel finding that emerged from this study was that expression of pIgR in CEC
was down-regulated in both acute DSS and chronic T cell colitis (Figure 3-3).
Furthermore, DSS-induced inflammation was associated with reduced epithelial
transcytosis of IgA (Figure 3-6A). These results were consistent with our findings in CD
patients with either acute or chronic colitis, in which expression of pIgR and transcytosis
of IgA in CEC was reduced compared to normal individuals or CD patients with mild
disease60. The importance of pIgR in prevention of intestinal inflammation is supported
by the report that pIgR-deficient mice were more susceptible to DSS-induced colitis than
were wild-type mice58. pIgR transports polymeric IgA from the basal to the apical surface
of intestinal epithelial cells, where proteolytic cleavage of the extracellular domain of
pIgR (secretory component, SC) releases secretory IgA (SIgA) into the intestinal
lumen44,132. Because one molecule of pIgR is synthesized for every molecule of IgA
transported, the level of pIgR expression controls the rate of epithelial transcytosis of
IgA. SIgA antibodies play a critical role in shaping the composition of the gut microbiota
and in maintenance of intestinal homeostasis45. SIgA binds to intestinal mucus via
glycan-mediated interactions, thus forming an immunological barrier to penetration of the

54

epithelial layer by microbes and environmental antigens, and can also neutralize antigens
and microbial products intracellularly during pIgR-mediated epithelial transcytosis. In
addition, pIgR can transport IgA-containing immune complexes across polarized IEC
monolayers, thus disposing of antigens through a non-inflammatory process 133. Thus,
reduction of pIgR expression during colitis would be predicted to diminish not only the
antimicrobial function of luminal SIgA, but also removal of IgA-bound antigens from the
lamina propria. These defects would exacerbate local inflammation and increase the
level of IgA immune complexes, a potential risk factor for development of IgA
nephropathy, which has been linked with IBD88.
It should be noted that a protective role for pIgR in the T cell transfer model of
colitis could not involve transcytosis of SIgA, since B cell-deficient recipient Rag1-/mice do not produce IgA. However, it is well known that free SC, which is released when
pIgR that is not associated with IgA is cleaved at the apical surface of epithelial cells,
contributes to intestinal homeostasis by inhibiting bacterial adherence to the intestinal
mucus layer and neutralizing of potential pro-inflammatory factors54,134. We found that
expression of pIgR mRNA was reduced (Fig. 2B) and the cellular localization of pIgR
protein was aberrant (Fig. 5B) in Rag1-/- mice adoptively transferred with Teff.
Importantly, co-administration of Treg prevented both of these defects. Taken together,
our results suggest that inflammation in the colon, whether due to innate immune
responses in the DSS model or adaptive immune responses in the T cell model, creates a
local environment that is not conducive to optimal expression and cellular trafficking of
pIgR.
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We found that epithelial expression of TNF was significantly increased in acute
DSS colitis (Fig. 2A) and contributed strongly to pro-inflammatory PC2, but not to
homeostatic PC1 values (Figure 3-4A). In contrast, altered epithelial expression of TNF
was not a feature of T cell-mediated chronic colitis (Figure 3-3B) and contributed to both
PC1 and PC2 values (Figure 3-4A). Although TNF expression was not elevated in CEC
of mice with T cell-mediated colitis, we cannot rule out the possibility that production of
TNF by other cell types contributes to intestinal inflammation in this model. We
previously reported that expression of TNF in mucosal biopsies (which contain stromal
and bone marrow-derived cells in addition to epithelial cells) was actually reduced in a
large subset of CD patients with longstanding, chronic inflammation60. We recently
reported that stimulation with TNF enhances expression of pIgR through a RelAdependent mechanism in a human CEC line 135, suggesting that physiological production
of TNF in the colonic epithelium may contribute to intestinal homeostasis by promoting
pIgR-mediated transcytosis of SIgA and innate immune functions of SC. However,
failure to regulate TNF production clearly contributes to the pathogenesis of IBD.
Biological therapies designed to neutralize TNF have been extremely useful in managing
severe colitis136, and a recent report suggests that anti-TNF therapy may promote the
activation and expansion of T regulatory cells in CD patients137. However, neutralization
of TNF can be associated with significant adverse effects, including exacerbation of
disease, serious infection and malignancies. Furthermore, anti-TNF therapies are only
effective in about half of patients, and there are as yet no clear clinical guidelines
regarding which anti-TNF drug to use first or how to manage patients who experience
recurrence of symptoms138. Our findings in CD patients and in experimental models of
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colitis suggest that monitoring TNF expression in the colonic mucosa may be useful for
understanding disease mechanisms and identifying those patients most likely to benefit
from anti-TNF therapy.
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Figure 3-1 Purification of T cells and colonic epithelial cells (CECs). T effector and T
regulatory cell populations for T cell transfer model of experimental colitis. (A) Single
cell suspensions of spleens from wild-type mice were separated into CD4+CD45RBhi
(fraction R3) and CD4+CD45RBlo fractions (fraction R4) by fluorescence-activated cell
sorting. (B) The histogram shows intensity of cell surface CD25 staining in the
CD4+CD45RBhi (black) and CD4+CD45RBlo (purple) fractions. (C) Purity of colonic
epithelial cells (CEC). Isolated CECs were analyzed for cell surface CD45 by flow
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Figure 3-1 (continued) cytometry. The major peak in each plot represents ECs, and the
gated area represents contaminating small CD45hi hematopoietic cells. (Frantz et al.
Multifactorial Patterns of Gene Expression in Colonic Epithelial Cells Predict Disease
Phenotypes in Experimental Colitis. Inflammatory Bowel Disease in press 2012.)
Reprinted with permission.
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Figure 3-2 Assessment of disease severity in DSS and T cell transfer colitis. DSS
colitis. Mice were left untreated or administered 2% or 3% DSS in the drinking water for
8 days. (A) Changes in body weight (expressed as a percentage of weight at the
beginning of the experiment) and disease activity (see Materials and Methods for an
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Figure 3-2 (continued) explanation of the disease activity index). Data from 1 of 3
independent experiments with similar results are expressed as mean ± SEM (n = 8). (B)
Colon lengths were measured on day 8; data combined from 3 independent experiments
are expressed as mean ± SEM (n = 16). (A, B) One asterisk indicates that the mean is
significantly different from the mean for control mice, and two asterisks indicate that the
mean is significantly different from the mean for both control mice and mice treated with
2% DSS (p < 0.05). (C) Colon histology from representative mice at day 8. Images of
formalin-fixed colon tissues stained with hematoxylin and eosin were captured with a
20X objective. (D-F) T cell transfer colitis. Rag1-/- mice were left untreated (control) or
adoptively transferred with 4 x 105 CD4+CD45RBhiCD25- T-effector cells (Teff), with or
without 1 x 105 CD4+CD45RBloCD25+ T-regulatory cells (Treg). (D) Changes in body
weight; data from 1 of 3 independent experiments with similar results are expressed as
mean ± SEM (n = 8). (E) Colons were measured and weighed at 10 weeks post-transfer;
data are expressed as mean ± SEM (n = 10). (D, E) An asterisk indicates that the mean is
significantly different from the mean for control Rag1-/- mice (p < 0.05). (F) Colon
histology from representative mice at 10 weeks post-transfer. Images of formalin-fixed
colon tissues stained with hematoxylin and eosin were captured with a 20X objective.
(Frantz et al. Multifactorial Patterns of Gene Expression in Colonic Epithelial Cells
Predict Disease Phenotypes in Experimental Colitis. Inflammatory Bowel Disease in
press 2012.) Reprinted with permission.
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Figure 3-3 Comparison of biomarker expression in colonic ECs in experimental
colitis: (A) DSS colitis; (B) T cell transfer colitis. Colitis was induced as described in
Figure 1, and colonic ECs were isolated at the end of the experiments. mRNA levels were
measured by qRT-PCR and normalized to β2-microglobulin mRNA. For each model,
data from 3 independent experiments were combined and expressed as mean ± SEM (n =
16 for DSS colitis and n = 10 for T cell transfer colitis). Asterisks indicate that the mean
for treated mice is different from the mean for control mice (p < 0.05). (Frantz et al.
Multifactorial Patterns of Gene Expression in Colonic Epithelial Cells Predict Disease
Phenotypes in Experimental Colitis. Inflammatory Bowel Disease in press 2012.)
Reprinted with permission.
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Figure 3-4 Multifactorial analysis of biomarker expression patterns in experimental
colitis, using data described in Figure 2 for mRNA levels in colonic ECs. (A) Factor
analysis was used to reduce data for 5 variables, NF-κB, RelA, A20, pIgR, TNF and
MIP-2, into two principal components (PCs). Eigen values indicate the proportion of
variance among mice in expression of these 5 variables that can be described by PC1 and
PC2. Weighted coefficients are listed for each variable comprising PC1 and PC2. (B)
PC1 and PC2 scores were calculated for each individual mouse based on the sum of
normalized expression levels for each variable multiplied by its corresponding coefficient
for PC1 and PC2 (see Materials and Methods). Combined data from 3 independent
experiments for each mouse model are expressed as mean ± SEM (n ≤ 14 mice/group for
DSS colitis and n = 10 mice/group for T cell transfer colitis). Asterisks indicate that the
mean PC values for the indicated comparisons are significantly different (p < 0.05); NS =
not significant. Reprinted with permission.
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Figure 3-5 Expression of colonic epithelial biomarkers predicts disease severity in
experimental colitis: (A) DSS colitis; (B) T cell transfer colitis. Plots depict linear
regression comparing PC1 and PC2 scores for each mouse to body weight at the end of
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Figure 3-5 (continued) the experiment, and colon length (DSS colitis) or the ratio of
colon weight to length (T cell transfer colitis). Correlation coefficients (r) and P-values
(p) are listed for each regression line. (Frantz et al. Multifactorial Patterns of Gene
Expression in Colonic Epithelial Cells Predict Disease Phenotypes in Experimental
Colitis. Inflammatory Bowel Disease in press 2012.) Reprinted with permission.
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Figure 3-6 Localization of pIgR and IgA in colonic mucosa of mice with
experimental colitis: (A) DSS colitis; (B) T cell transfer colitis. Sections of formalinfixed colons were stained by immunofluorescence for pIgR (green), IgA (red) and nuclei
(DAPI; blue). Representative images are shown for each treatment group. Images were
captured with a 25X objective. (Frantz et al. Multifactorial Patterns of Gene Expression
in Colonic Epithelial Cells Predict Disease Phenotypes in Experimental Colitis.
Inflammatory Bowel Disease in press 2012.) Reprinted with permission.
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Chapter Four: Regulation of pIgR expression by commensal bacteria in human
intestinal epithelial cells

Introduction
The mammalian gut is home to an estimated one trillion bacteria and it is the
responsibility of the intestinal epithelium to separate this vast number of bacteria from
host tissue6. Secretory IgA antibodies, transported across intestinal epithelial cells (IEC)
by the polymeric immunoglobulin receptor (pIgR), provide the first line of defense
against potentially harmful bacteria44,132. This transport process provides multiple levels
of immune protection: Excretion of IgA-containing immune complexes; transcytosis of
SIgA has been shown to neutralize viruses and microbial products within IEC55; release
of SIgA at the apical surface of the epithelium serves as a physical barrier, limiting
bacterial adherence translocation44,56; and secretory component, the cleaved extracellular
domain of pIgR, unbound to IgA has been shown to contribute to innate immunity by
acting as a non-specific bacterial scavenger and limiting inflammatory immune
response54. One molecule of pIgR is consumed for every molecule of SIgA transported
into the lumen, thus the rate of pIgR transcription controls the rate of SIgA transcytosis
and high expression of pIgR is required to maintain sufficient supply of SIgA and SC44.
Accordingly, steady-state levels of pIgR mRNA in mouse and human IEC are very high.
We have shown that expression of pIgR is much higher in the colon than in the ileum of
both healthy controls and CD patients, which is likely due to enhanced bacterial
stimulation of IECs due to greater numbers of commensal bacteria60. However, the
mechanisms by which IEC maintain high levels of pIgR expression while limiting
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inflammatory immune responses in the face of the vast microbial community are not
completely understood. Therefore the aim of this chapter is to dissect the molecular
mechanism by which pIgR expression is regulated in IEC by commensal bacteria and
compare this to the regulation of the pro-inflammatory response.
Cross-talk between commensal bacteria and IEC is mediated by patternrecognition receptors, including Toll-like receptors (TLRs)6. While TLR signaling is
capable of triggering inflammation in response to microbial insult, these innate immune
receptors establish intestinal homeostasis by discriminating between symbiotic
commensal bacterial and harmful pathogens6. Accordingly, IEC TLR signaling identifies
the composition of the local microbiota and instructs the underlying effector and
regulatory immune cells, with the ultimate function to dampen inflammation while
providing immune protection6,139,140. This process involves production and transport of
large quantities of IgA in order to maintain this balance140. Previous studies from our lab
have demonstrated that stimulation of TLR3 and TLR4 with purified ligands induces
pIgR expression in IEC in vitro141. TLRs that sense microbial components require the
cytoplasmic adaptor protein, MyD88 to activate downstream signaling pathways. MyD88
deficiency results in significant impairment of intestinal IgA responses and
homeostasis62,142. However, the role of IEC MyD88-dependent TLR signaling in the
regulation of pIgR expression is unclear.
MyD88-dependent TLR signaling leads to the activation of nuclear factor –κB
(NF-κB)27 signaling pathways and parallel activation of several mitogen-activated protein
kinases (MAPK) including c-Jun N-terminal kinase (JNK), extracellular signal-regulated
kinase ERK (ERK), and p38 MAPK26. Accordingly, NF-κB and MAPK activation is
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significantly reduced in MyD88-deficient mice28. However, the contributions of these
pathways in the induction of pIgR by bacterial stimulation have not been investigated.
The NF-κB family of transcription factors consists of five members in mammals, RelA,
RelB, c-Rel, p50 and p5231. These NF-κB proteins can form homo- or heterodimers that
bind DNA consensus sequences on target genes to regulate gene transcription. Inactive
NF-κB is localized to the cytoplasm in association with IκB inhibitory proteins.
However, upon stimulation, phosphorylation and degradation of IκB proteins occurs,
resulting in the nuclear translocation of NF-κB dimers30. Two NF-κB signaling
pathways have been identified. The classical RelA-dependent pathway is activated
primarily by pro-inflammatory cytokines and TLR ligands, leading to the degradation of
IκBa and the nuclear translocation of RelA/p50 heterodimers31. The translocation of
RelA/p50 into the nucleus leads to the activation of gene transcription, including the
rapid induction of several pro-inflammatory chemokines and cytokines, such as IL-8 and
TNF, which comprise the early pro-inflammatory response143. This early proinflammatory response is quickly downregulated by negative regulators within hours of
induction144. In contrast, the induction of pIgR by pro-inflammatory cytokines and TLR
ligands is slow and sustained, peaking at 24 hours and remaining high141,143. The
alternative NF-κB pathway is primarily activated by a limited number of stimuli
including lymphotoxin B and B-cell activating factor (BAFF) and involves the nuclear
translocation of RelB/52 dimers31,145. Although NF-κB signalling in the intestine has
been studied extensively, the differential roles of the classical RelA-dependent or the
alternative RelB-dependent pathway are not fully understood due to its complex nature
and the intrinsic variability in different cell types146. Our lab has previously
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demonstrated that transcription of the PIGR gene, in response to TNF and TLR signaling,
requires a κB element in the first intron that is a perfect match to the RelA consensus
sequence147. Additional studies using siRNA have shown that de novo synthesis of RelB
is required for optimal TNF-mediated induction of pIgR148. This chapter will investigate
the contributions of the classical and alternative NF-κB pathways in the induction of
pIgR transcription under the hypothesis that these factors may have differential roles in
the maintenance of pIgR expression and the induction of pro-inflammatory immune
responses. By utilizing chemical inhibitors and intestinal epithelial cell lines in which the
expression of critical components of these signaling pathways are knocked down,
stimulus-specific mechanistic differences in the regulation of pIgR and pro-inflammatory
gene expression in intestinal epithelial cells are examined.

Results
Activation of the NF-κB pathway by TNF and TLR signaling is required to induce
pIgR expression.
To determine if the RelA-dependent NF-κB pathway is required for the induction
of pIgR expression, the human IEC line HT-29 cells was stimulated with TNF or ligands
for TLR4 (lipopolysaccharide (LPS)) or TLR3 (polyinosinic:polycytidylic acid (pIC)), in
the presence or absence of BAY 11-7082, an inhibitor of IκBa phosphorylation (Figure
4-1). Consistent with previous reports from our lab using this cell line, IL-8 mRNA
levels rapidly increased following 3 hours of stimulation with TNF or TLR ligands,
indicative of the early pro-inflammatory response. Likewise, induction of IL-8 by all
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three ligands was inhibited by BAY11-7082, suggesting that this early pro-inflammatory
response induced by TNF and TLR signaling in IECs involves the classical NF-κB
pathway. The varying magnitude of IL-8 induction by TNF, LPS and pIC, as well as the
varying degree of IL-8 inhibition in the presence of BAY 11-7082, suggests that NF-κB
activation may be stimulus-specific and/or there may be additional contributions from
other signaling pathways in the regulation of the early pro-inflammatory response.
Alternatively, induction of pIgR was delayed until 24 hours of TNF or TLR stimulation,
consistent with previous published results from our lab, and the magnitude of induction
was similar for all three stimuli. Additionally, pIgR induction in response to all three
stimuli was completely inhibited in the presence of BAY 11-7082B, indicating that pIgR
induction by TNF and TLR signaling requires activation of the classical NF-κB pathway.
These results are not specific to the HT-29 cell line because similar results were observed
when using another human IEC line, LoVo cells (Figure 4-2). Other colon carcinoma
cell lines, including CaCo2, SW480 and LS174T, were also tested (data not shown);
however, while similar NF-κB-dependent gene expression was observed in these cell
lines, pIgR mRNA levels were extremely variable. Therefore, since HT-29 cells are a
well established model for studying IEC responses and the regulation of pIgR, all
additional in vitro cell culture experiments have been performed using HT-29 cells. Our
lab has previously demonstrated that changes in mRNA levels in response to various
stimuli are directly proportional to changes in protein expression for pIgR and IL-8 in
HT-29 cells. Taken together, these results suggest that the early pro-inflammatory
response and the delayed induction of pIgR expression in human IECs require activation
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of the classical NF-κB pathway, yet the contributions of the RelA-dependent NF-κB
pathway in these responses may be different.

Differential contributions of the classical NF-κB pathway to the induction of early
inflammatory response genes and the induction of pIgR expression
To investigate the mechanisms that regulate the early induction of proinflammatory genes and the delayed induction of pIgR in IEC by TNF and TLR
signaling, control, RelA and RelB knockdown cells were stimulated with TNF, LPS or
pIC for 3 and 24 hours (Figure 4-3). The early pro-inflammatory response, characterized
by the induction of IL-8 and TNF expression, was significantly inhibited in the RelA
knockdown cells, particularly in response to TLR signaling. Knockdown of RelA also
inhibited the induction of A20, the cytoplasmic ubiquitin-editing enzyme that acts as a
negative feedback regulator of the classical NF-κB pathway. While, knockdown of RelB
had little effect on the induction of gene expression in response to LPS or pIC
stimulation, RelB knockdown partially inhibited TNF-stimulated induction of early
response genes, indicating an involvement of the alternative NF-κB pathway.
Knockdown of RelA inhibited the late induction of pIgR in response to TNF
stimulation but not to stimulation by TLR ligands. Interestingly, the steady-state levels
of pIgR mRNA were significantly higher in RelB knockdown cells, as compared to
control and RelA knockdown cells, indicating a potential inhibitory effect of RelB on
pIgR expression. Accordingly, RelB knockdown did not inhibit the up-regulation of pIgR
expression in response to any stimuli, but further increases in pIgR mRNA were observed
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upon stimulation. Taken together, these results suggest that the classical RelA-dependent
NF-κB pathway is required for the regulation of pIgR expression by TNF signaling,
however additional signaling pathways may be able to compensate to promote the
induction of pIgR in response to TLR signaling. To ensure that inhibition of RelA by
siRNA did not have indirect effects on the MAPK signaling pathway, the expression of
MAPK-phosphotase 1 (MKP-1) was analyzed. MKP-1, the phosphotase that
downregulates MAPK signaling, contains multiple MAPK-responsive elements in its
promoter region, but it does not contain any κB-binding sites and should not be directly
affected by NF-κB inhibition. Accordingly, only minor changes in MKP-1 levels were
observed in RelA or RelB knockdown cells, suggesting the NF-κB knockdown did not
significantly affect MAPK signaling.

Differential contributions of the MAPK signaling pathway in the regulation of the
early pro-inflammatory response and the polymeric immunoglobulin receptor
It has been well established that stimulation of TNF and TLR signaling leads to
the activation of not only NF-kB signaling, but additional signaling pathways, including
MAPK signaling. To investigate the role of MAPK signaling in regulating expression of
early pro-inflammatory genes and the late induction of pIgR in response to TNF and TLR
signaling, HT-29 cells were stimulated with TNF, LPS or pIC in the presence of
individual MAPK inhibitors (inhibitors to p38, JNK, and ERK) or a combination of all
three inhibitors (Figure 4-4). Inhibition of p38 and ERK signaling significantly reduced
the induction of IL-8 in response to TNF and pIC, while inhibition of JNK had no effect
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on this early pro-inflammatory response. Likewise, the combination of all three MAPK
inhibitors prevented the induction of IL-8 in response to all three stimuli, suggesting that
these MAPK pathways work synergistically to regulate the early pro-inflammatory
response. Alternatively, inhibition of MAPK signaling did not inhibit the induction of
pIgR, rather, inhibition of p38 as well as a combination of all three inhibitors actually
enhanced induction of pIgR in response to TNF and pIC. These results are consistent
with previous work that demonstrated that TNF-induced expression of pIgR in HT-29
cells was enhanced when ERK activation was inhibited. Induction of pIgR by LPS was
not affected by any MAPK inhibitors149. Taken together, these results suggest that
MAPK signaling, while stimulus-specific, plays different roles in regulating the early
pro-inflammatory response and the late induction of pIgR. Specifically, MAPK signaling
pathways act synergistically to enhance expression of pro-inflammatory genes, while
inhibiting the late induction of pIgR.

pIgR expression is regulated by TLR4 signaling in intestinal epithelial cells
These results indicate that multiple signaling pathways may function to maintain
pIgR expression in IECs, particularly in response to bacterial-induced TLR signaling.
However, it is generally accepted that IEC are “hyporesponsive” to constant stimulation
with intestinal bacteria, maintaining immune tolerance to prevent excessive
inflammation6,17. This idea is supported by the observation from our lab that when
stimulated with various species representing the four major phyla of colonic bacteria,
HT-29 cells only responded to stimulation from bacteria in the family
Enterobacteriacceae62. To investigate the mechanism underlying the hyporesponsiveness
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of intestinal epithelial cells to commensal bacteria and the maintenance of pIgR
expression, HT-29 human intestinal epithelial cell line and THP-1 human monocyte cell
line were stimulated with purified E. coli (Enterobacteriaceae family) LPS, a ligand for
TLR4, and Pam3CSK4, a ligand for TLR2. These ligands were chosen due to their ligand
preferences and spatially restricted expression by IECs. While TLR2, TLR4 and TLR5 all
recognize bacterial components and are expressed on the epithelial surface of IECs,
TLR4 and TLR2 have been shown to be expressed on the apical surface of epithelial
cells, as opposed to TLR5 which is only expressed on the basolateral surface of IECs6.
Consistent with previous published work, pIgR expression was induced upon activation
of TLR4 (Figure 4-5A). However, induction of pIgR was not observed in response to
TLR2 activation. The unresponsiveness to PamCSK4 stimulation was not gene specific
because IL-8 expression was not induced upon TLR2 signaling, but was significantly
induced in response to TLR4 signaling in HT29 cells (Figure 4-5B). In contrast, THP-1
monocytes induced very high levels of IL-8 mRNA in response to either TLR2 or TLR4
signaling. One possible explanation for the hyporesponsiveness of HT-29 cells to TLR2
stimulation is the observation that THP1 cells express 2000-fold higher levels of TLR2
mRNA than HT-29 cells. Alternatively expression of TLR4, as well as the cytoplasmic
adaptor protein MyD88, was relatively similar between the IEC and monocyte cell-lines
(Figure 4-5). To determine whether the hyporesponsiveness of IEC was due to the
inhibition of TLR signaling, the expression of TLR signaling inhibitors, the TLR decoy
receptor, Single Ig IL-1-related receptor (SIGIRR) and the Toll-interacting protein
(TOLLIP), a cytoplasmic protein that binds to the intracellular domains of TLRs to
inhibit IRAK phosphorylation and downstream signaling, were analyzed. The basal level
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of SIGIRR was 3-fold higher in HT-29 cells, compared to THP-1 cells, and expression of
this TLR inhibitor was not downregulated in response to TLR signaling in HT-29 cells,
as observed in THP-1 cells. Likewise, while the basal level of TOLLIP was slightly
lower in HT-29 cells, expression of this TLR inhibitor was significantly upregulated in
response to TLR stimulation, which was not observed in THP-1 cells. Taken together,
these results suggest that the hyporesponsiveness of IEC to colonic bacteria may be a
result of reduced TLR2 signaling as well as the upregulation of TLR signaling inhibitors.
To investigate the hypothesis that pIgR induction by commensal bacteria is
dependent on TLR4 signaling, HT-29 cells were stimulated with E.coli strain Nissle
(EcN) for 24 hours in the presence of increasing concentrations of polymixin B, an
antibiotic that neutralizes LPS, inhibiting activation of TLR4 (Figure 4-6). Accordingly,
while EcN stimulation significantly induced pIgR expression, this induction was
inhibited in a dose-dependent manner in the presence of polymixin B. These results
indicate induction of pIgR by colonic bacteria is primarily dependent on the activation of
TLR4 signaling by LPS.

Gene expression induced by colonic bacteria is dependent on intestinal epithelial
MyD88 signaling
Ligation of TLR4 leads to the recruitment of the cytoplasmic adaptor protein
MyD88. We have recently reported that the steady-state levels of pIgR mRNA was
significantly reduced in MyD88 deficient mice62. However, in this study it was not
determined whether pIgR expression was regulated directly by MyD88 signaling in IEC

77

or indirectly by immune cells in the lamina propria62. To investigate the hypothesis that
MyD88 signaling in IEC regulates pIgR expression in response to colonic bacteria, HT29 cells were stably transfected with shRNA directed against MyD88, or an irrelevant
control. Significant knockdown of MyD88 expression was achieved in shRNA
transfected cells (Figure 4-7). Stimulation with EcN for 3 hours upregulated MyD88
expression in both control and MyD88 knockdown cells, but the expression of MyD88 in
the knockdown cells was less than unstimulated control cells. Likewise, EcN induced
expression of IL-8, which peaked at 3hrs in control transfected cells, but this induction
was significantly inhibited in MyD88 knockdown cells. Similarly, EcN induced pIgR
expression by 24 hours in control transfected cells, but induction of pIgR was
significantly inhibited in MyD88 knockdown cells. Furthermore, correlation analysis
revealed a strong positive correlation between MyD88 expression and IL-8 and pIgR
expression. These results suggest that the induction of both IL-8 and pIgR in response to
commensal bacteria is dependent on intestinal epithelial MyD88 signaling.

Induction of pIgR by E. coli is dependent on NF-κB signaling, but not MAPK
signaling
Activation of MyD88-dependent TLR signaling leads to the activation of the NFκB and MAPK signaling pathways, resulting in the induction of gene expression. To
investigate the contribution of these downstream signaling pathways to the induction of
early pro-inflammatory genes and late pIgR expression in response to colonic bacteria,
HT-29 cells were stimulated for 3 or 24 hours in the presence or absence of Bay 11-7082,
an inhibitor of NF-κB, or inhibitors to the MAPK signaling pathways. Inhibition of NF78

κB activation completely inhibited the induction of both IL-8 and pIgR in response to E.
coli stimulation (Figure 4-8A), suggesting NF-κB signaling is required to induce IL-8
and pIgR expression in response to colonic bacteria. To determine the contributions of
RelA and RelB in the induction of IL-8 and pIgR in response to colonic bacteria, RelA a
RelB knockdown cells were stimulated with EcN for 3 or 24 hours (Figure 4-8B).
Inhibition of RelA significantly reduced the induction of IL-8, while inhibition of RelB
had no effect. Alternatively, inhibition of either RelA or RelB had no effect on the
upregulation of pIgR in response to EcN. These results indicate that while IL-8 induction
is dependent on the classical RelA pathway of NF-κB activation, RelA and RelB may be
interchangeable for the induction of pIgR by colonic bacteria. Inhibition of the p38
MAPK pathway, but not the ERK or JNK MAPK pathway, significantly reduced the
induction of IL-8 by EcN (Figure 4-9). However, none of the MAPK inhibitors had any
effect on the induction of pIgR by EcN (Figure 4-9). Taken together, these findings
suggest that while both the early pro-inflammatory response and the late pIgR response
requires MyD88-dependent TLR4 signaling in IEC, these responses have distinct
downstream signaling requirements. The activation of the early pro-inflammatory genes
in response to EcN is dependent on activation of p38 and the classical RelA-dependent
NF-κB pathway, while the late induction of pIgR requires NF-κB activation, but is
independent of MAPK signaling.

Discussion
The function of NF-κB signaling in the intestine epithelium is complex. A
balance of inflammatory and anti-inflammatory immune responses must be maintained to
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ensure adequate protection against potential pathogens while preventing collateral
damage to the intestinal epithelium30. Several mouse models support the idea that
hyperactivation of NF-κB contributes to intestinal inflammation. In particular, mice
lacking epithelial-specific expression of SIGIRR, the negative regulator of TLRdependent NF-κB activity, develop much more severe DSS-induced colonic
inflammation82. These results suggest that bacterial-induced hyperactivation of NF-κB
could be sufficient for promoting intestinal inflammation and maintaining a level of NFκB hyporesponsiveness may be beneficial in response to significant bacterial stimulation.
On the other hand, ablation of NF-κB in the intestinal epithelium is also associated with
inflammation. Loss of epithelial-specific NF-κB activity by deletion of epithelial-NEMO
causes severe spontaneous colitis in mice34. Mice with a targeted deletion of Rela in IECs
exhibited reduced expression of pro-restitution genes, increased epithelial apoptosis and
increased susceptibility to DSS-induced acute colitis30. Furthermore, while individual
ablation of IKK1 or IKK2 in IECs is insufficient to cause spontaneous inflammation¸
mice deficient in both IKK1 and IKK2 develop colitis similar to epithelial-specific
NEMO-deficient mice34; thus, the classical NF-κB pathway, or at least functional IKK1
or IKK2, is essential in maintaining intestinal homeostasis. Accordingly, these new
findings presented here suggest that regulation of pIgR expression in IECs may be an
important mechanism by which NF-κB maintains intestinal homeostasis during proinflammatory immune responses. Here we show that while the induction of pIgR by
soluble ligands, including TNF and TLR ligands, is dependent on NF-κB signaling, the
specific contributions of the classical and alternative NF-κB pathways are stimulus
specific. In particular, by inhibiting RelA expression, we demonstrated that the TNF80

stimulated upregulation of pIgR expression requires the classical NF-κB signaling
pathway. These results are supported by the abolishment of transcriptional activity of a
PIGR reporter gene in these RelA knockdown HT-29 cells in response to TNF
stimulation105. Alternatively, the regulation of pIgR expression by TLR signaling appears
to involve both the classical and alternative NF-κB pathways. Similar to TNF
stimulation, inhibiting IκBα phosphorylation significantly inhibited pIgR induction in
response to LPS and pIC, which is supported by the observation that the transcriptional
activity of a PIGR reporter gene was significantly reduced in RelA knockdown HT-29
cells105. However, knockdown of either RelA or RelB did not inhibit the induction of
pIgR mRNA levels following LPS or pIC stimulation. These results suggests that the
classical and alternative NF-κB signaling pathways, as well as additional pathways, may
be able to compensate for the loss of either RelA or RelB in order to maintain pIgR
expression in the presence of bacterial stimulation.
Although our results suggest that additional signaling pathways may contribute to
the regulation of pIgR expression, inhibition of MAP kinases, which are known to be
activated by TNF and TLR signaling, did not block induction of pIgR. In particular,
inhibition of ERK activation actually increased pIgR expression, which is consistent with
previous reports149. In contrast, MAPK activation was required for the early induction of
IL-8 expression, highlighting the mechanistic differences in the regulation of the early
pro-inflammatory response and the slow and sustained induction of pIgR expression.
Taken together, these results suggest that the regulation of pIgR expression in intestinal
epithelial cells may be an important mechanism by which NF-κB maintains intestinal
homeostasis during pro-inflammatory responses. Furthermore, by utilizing signaling
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pathways that are distinct from those involved in regulating the early pro-inflammatory
response, IECs are able to upregulate pIgR expression in response to microbial and host
stimuli while suppressing a potentially damaging pro-inflammatory response.
This hyporesponsiveness, or suppression of pro-inflammatory responses, by IECs
in response to bacterial stimulation is highlighted by the observation that HT-29 cells
respond to purified LPS and whole EcN, although not as robustly as the THP-1 monocyte
cell lines. Alternatively, HT-29 cells were unresponsive to TLR2 stimulation, unlike
THP-1 cells. Consistent with these results, we found that while IECs express very low
levels of TLR2, expression of TLR4 and MyD88 is similar between cell types and are
upregulated by pro-inflammatory stimuli. Furthermore, induction of pIgR by whole E.
coli was primarily dependent on the TLR4-activation of MyD88 signaling. Interestingly,
studies examining the structural requirements for TLR4-mediated signaling indicate that
LPS molecules from only a limited group of Gram-negative bacteria, specifically those of
the family Enterobacteriaceae, have the ability to act as a TLR4 ligand150,151. LPS
molecules from other Gram-negative commensal bacteria signal through TLR2 rather
than TLR4152. Unlike TLR2 expression, which remained low following stimulation with
PAM3CSK4, TLR4 expression was upregulated in response to E. coli LPS. Moreover, it
has previously been demonstrated that IgA can neutralize E. coli LPS within IECs56.
Taken together, these results suggests a negative-feedback, anti-inflammatory role for
intracellular SIgA in response to TLR4 signaling. Accordingly, induction of pIgR
expression by a subset of commensal bacteria may be a mechanism by which IECs
maintain pIgR expression while limiting pro-inflammatory responses in the face of
continuous interactions with gut bacteria. Consistent with this idea, our lab demonstrated
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that pIgR expression was selectively upregulated in response to bacteria from the family
Enterobacteriaceae of the phylum Proteobacteria, suggesting that different types of
colonic bacteria differentially regulate pIgR expression in IEC.62
Similar to results using purified ligands, we demonstrate that induction of the proinflammatory chemokine, IL-8, by EcN in HT-29 cells requires both NF-κB and p38
MAPK signaling. Consistent with previous results, the increase in IL-8 was rapid and
transient, returning to near base-line levels following 24 hours of EcN stimulation. In
contrast, the slow and sustained induction of pIgR expression by EcN required NF-κB
signaling, but not MAPK signaling. In support of these results, our lab has shown that
EcN induced expression of a negative regulator of MAPK signaling, MKP-1, in HT-29
cells. Also, we have shown that MKP-1 levels are 16-fold higher in the colon than in the
small intestine of mice, consistent with the increase bacterial load. Furthermore, these
levels are significantly reduced in MyD88 deficient mice62. Accordingly, these results
suggest that limiting MAPK signaling may be an important role of MyD88-dependent
TLR signaling by a subset of commensal bacteria.
Overall, the results presented here demonstrate that IEC utilize distinct
mechanisms to regulate the expression of the early pro-inflammatory response and the
late and sustained pIgR response in efforts to maintain intestinal homeostasis.
Specifically, stimulation of pIgR expression by a subset of commensal bacteria or host
stimuli would enhance pIgR-mediated transport of protective IgA antibodies, as well as
innate immune functions mediated by SC. Transient induction of moderate levels of IL-8
by IECs, at much lower levels than induced by byproducts of viral replication or other
non-bacterial stimuli141, would promote influx of neutrophils in sufficient quantities to
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enhance innate immunity without excess inflammation. This early pro-inflammatory
response is rapidly followed by the induction of negative regulatory molecules, such as
MKP-1, Tollip and Sigirr, that would prevent excess activation of NF-κB and MAPK
signaling. Therefore, cross-talk between commensal bacteria and IECs is crucial for
regulating the levels of NF-κB activity and maintaining of intestinal homeostasis.
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Figure 4-1 Activation of the classical NF-κB pathway by TNF, LPS, and pIC in
intestinal epithelial cells. HT-29 cells were stimulated with TNF (10 ng/ml), LPS
(1mg/ml), or pIC (100mg/ml) for 3 or 24 h, in the presence or absence of 10 mM
BAY11-7082, an inhibitor of IκBα phosphorylation. Cells cultured in the absence of
BAY 11-7082 were treated with an equivalent volume of vehicle (DMSO). mRNA levels
for IL-8 and pIgR were quantified by quantitative reverse transcriptase- PCR (qRT-PCR)
and normalized to GAPDH mRNA. Data from three independent experiments were
combined and expressed as mean ± s.e.m. ( n = 9): a , the mean for stimulated cells is
significantly greater than the mean for unstimulated cells ( P < 0.05); b, the mean for
cells treated with BAY 11-7082 is significantly different from the mean for cells given
the same stimulus in the absence of BAY 11-7082 ( P < 0.05). (Bruno, M.E., Frantz,
A.L., Rogier, E.W., Johansen, F.E. & Kaetzel, C.S. Regulation of the polymeric
immunoglobulin receptor by the classical and alternative NF-kappaB pathways in
intestinal epithelial cells. Mucosal Immunol 4, 468-478(2011)) Reprinted with
permission.
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Figure 4-2 Effect of NF-κB inhibition on the response of the LoVo human IEC line
to LPS, pIC and TNF. LoVo cells were stimulated with TNF (10ng/ml), LPS (1mg/ml)
or pIC (100 mg/ml) for 3 or 24 h, in the presence or absence of 10 μM BAY 11-7082, an
inhibitor of IκBα phosphorylation. Cells cultured in the absence of BAY 11-7082 were
treated with an equivalent volume of vehicle (DMSO). mRNA levels for IL-8 and pIgR
were quantified by qRT-PCR and normalized to GAPDH mRNA. Data are expressed as
mean ± SEM (n = 4): a, the mean for stimulated cells is significantly greater than the
mean for unstimulated cells (p < 0.05); b, the mean for cells treated with BAY 11-7082 is
significantly different from the mean for cells given the same stimulus in the absence of
BAY 11-7082 (p < 0.05). (Bruno, M.E., Frantz, A.L., Rogier, E.W., Johansen, F.E. &
Kaetzel, C.S. Regulation of the polymeric immunoglobulin receptor by the classical and
alternative NF-kappaB pathways in intestinal epithelial cells. Mucosal Immunol 4, 468478(2011)) Reprinted with permission.
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Figure 4-3 Effect of RelA and RelB knockdown on TNF, LPS, and pIC stimulated
gene expression. mRNA levels were analyzed by quantitative reverse transcriptase-PCR
(qRT-PCR) in HT-29 cells stably transfected with control, RelA, or RelB small inhibitory
RNAs (siRNAs) and treated with TNF (10 ng/ml ), LPS (1 mg/ml), or pIC (100 mg/ml )
for 3 or 24 h. Data from two to three independent experiments were combined and
expressed as mean ± s.e.m. ( n = 8 – 12): a, the mean for stimulated cells is significantly
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Figure 4-3 (continued) greater than the mean for unstimulated cells expressing the same
siRNA ( P < 0.05); b , the mean for cells expressing RelA or RelB siRNA is significantly
different from the mean for cells expressing control siRNA given the same stimulus for
the same length of time ( P < 0.05). (Bruno, M.E., Frantz, A.L., Rogier, E.W., Johansen,
F.E. & Kaetzel, C.S. Regulation of the polymeric immunoglobulin receptor by the
classical and alternative NF-kappaB pathways in intestinal epithelial cells. Mucosal
Immunol 4, 468-478(2011)) Reprinted with permission.
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Figure 4-4 Effect of MAPK inhibition on the response of HT-29 cells to tumor
necrosis factor TNF, LPS, and pIC. HT-29 cells were stimulated with TNF (10 ng/ml),
LPS (1mg/ml), or pIC (100 mg/ml) for 3 or 24 h, in the presence or absence of individual
MAPK inhibitors or a combination of the three inhibitors at the same concentrations (10
mM SB20358, p38 inhibitor; 10 mM SP600125, c-Jun N-terminal kinase (JNK) inhibitor;
10 mM PD98059, extracellular-regulated kinase (ERK) inhibitor). Cells cultured in the
absence of MAPK inhibitors were treated with an equivalent volume of vehicle DMSO.
mRNA levels for IL-8 and pIgR were quantified by quantitative reverse transcriptasePCR (qRT-PCR) and normalized to GAPDH mRNA. Data from two independent
experiments were combined and expressed as mean ± s.e.m.( n = 8): a , the mean for
stimulated cells is significantly greater than the mean for unstimulated cells ( P < 0.05);
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Figure 4-4 (continued) b, the mean for cells treated with MAPK inhibitors is
significantly different from the mean for cells given the same stimulus in the absence of
MAPK inhibitors ( P < 0.05). (Bruno, M.E., Frantz, A.L., Rogier, E.W., Johansen, F.E.
& Kaetzel, C.S. Regulation of the polymeric immunoglobulin receptor by the classical
and alternative NF-kB pathways in intestinal epithelial cells. Mucosal Immunol 4, 468478(2011)) Reprinted with permission.
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Figure 4-5: Regulation of gene expression by purified ligands for TLR2 and TLR4.
A. HT-29 cells were cultured for 24 h in the absence or presence of Pam3CSK4 (TLR2
ligand) or highly purified LPS from E. coli O26:B6 (TLR4 ligand), each at a
concentration of 1 μg/ml. mRNA levels were quantified by qRT-PCR and normalized to
GAPDH mRNA. B. HT-29 and THP-1 cells were cultured for 3 h in the absence or
presence of Pam3CSK4 or LPS, and mRNA levels were analyzed as described for panel
A. Data from 2 independent experiments were combined and expressed as mean ± SEM

91

Figure 4-5 (continued) (n = 8). Asterisks indicate that the mean is significantly different
from the corresponding mean for untreated cells from the same cell-line (p < 0.05).
(Bruno, M.E. et al. Regulation of the polymeric immunoglobulin receptor in intestinal
epithelial cells by Enterobacteriaceae: implications for mucosal homeostasis. Immunol
Invest 39, 356-382 (2010)) Reprinted with permission.
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Figure 4-6 Effect of TLR4 inhibition on the induction of pIgR expression by E. coli
Nissle. HT-29 cells were stimulated with EcN in the presence or absence of varying
concentrations of Polymyxin B, an inhibitor of LPS. mRNA levels were quantified by
qRT-PCR, normalized to b2-M mRNA, and expressed as mean ± SEM (n = 6). Astericks
indicate that the mean is significantly different for the indicated treatment groups (p
<0.01); N.S., not significant. Data from 2 independent experiments were combined and
expressed as mean ± SEM (n = 8)
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Figure 4-7. shRNA-mediated knockdown of MyD88 mRNA in a human colon
carcinoma cell-line HT-29. Clones of HT-29 cells stably transfected with the indicated
shRNA were stimulated with 106 E coli for 3 and 24 hours. mRNA levels were quantified
by qRT-PCR, normalized to b2-microglobulin mRNA, and expressed as mean ± SEM (n
= 6): a, mean for cells treated with E. coli is significantly different from the
corresponding mean for untreated cells; b, mean for cells expressing MyD88 shRNA is
significantly different from the mean for cells expressing control siRNA (p < 0.05).
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Figure 4-8: Effect of NF-κB inhibition on the response of HT-29 cells to E. coli
Nissle. A. HT-29 cells were stimulated for 3 or 24 h with heat-killed EcN, at a ratio of 10
bacterial cells per eukaryotic cell, in the presence or absence of 10 μM Bay 11 7082.
mRNA levels were quantified by qRT PCR and normalized to GAPDH mRNA. Data
from 3 independent experiments were combined and expressed as mean ± SEM (n = 9):
a, mean for cells stimulated with EcN is significantly different from the corresponding
mean for unstimulated cells; b, mean for cells treated with Bay 11-7082 is significantly
different from the corresponding mean for untreated cells. (Bruno, M.E. et al. Regulation
of the polymeric immunoglobulin receptor in intestinal epithelial cells by
Enterobacteriaceae: implications for mucosal homeostasis. Immunol Invest 39, 356-382
(2010)) Reprinted with permission. B. HT-29 cells expressing the indicated siRNA were
stimulated with EcN. mRNA levels were quantified by qRT-PCR, normalized to GAPDH
mRNA, and expressed as mean ± SEM (n = 4): a, mean for cells treated with EcN is
significantly different from the mean for untreated cells; b, mean for cells expressing
RelA or RelB siRNA is significantly different from the mean for cells expressing control
siRNA (p < 0.05).
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Figure 4-9: Effect of MAPK inhibition on the response of HT-29 cells to E. coli
Nissle. HT-29 cells were stimulated with EcN for 3 or 24 h in the presence or absence of
MAPK inhibitors (PD98059, ERK inhibitor; SB20358, p38 inhibitor; SP600125, JNK
inhibitor), individually or combined, each at a concentration of 10 μM. mRNA levels
were quantified by qRT PCR and normalized to GAPDH mRNA. Data from 2
independent experiments were combined and expressed as mean ± SEM (n = 8): a, mean
for cells stimulated with EcN is significantly different from the corresponding mean for
unstimulated cells; b, mean for cells treated with MAPK inhibitors is significantly
different from the corresponding mean for untreated cells. (Bruno, M.E. et al. Regulation
of the polymeric immunoglobulin receptor in intestinal epithelial cells by
Enterobacteriaceae: implications for mucosal homeostasis. Immunol Invest 39, 356-382
(2010)). Reprinted with permission.
Copyright © Aubrey L. Frantz 2012
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Chapter Five: Targeted deletion of MyD88 in intestinal epithelial cells results in
compromised antibacterial immunity associated with down-regulation of polymeric
immunoglobulin receptor, mucin-2 and antibacterial peptides

Introduction
The mammalian intestine harbors an estimated 100 trillion microorganisms,
which normally maintain a mutually beneficial relationship with the host.40 The intestinal
epithelium provides a physical barrier as well as innate immune defense, preventing this
vast community of microbes from entering host tissues.153 Defects in epithelial barrier
and immune functions can lead to infections with opportunistic and pathogenic
microbes154 and contribute to the etiology of inflammatory bowel disease (IBD).155
Cross-talk between the gut microbiota and intestinal epithelial cells (IECs) is mediated by
pattern recognition receptors, including the Toll-like receptor (TLR) family,156 leading to
expression of gene products that enhance epithelial barrier function and innate immunity.
TLR signaling in the gut is a double-edged sword; whereas physiological TLR signaling
promotes intestinal homeostasis in healthy individuals, excessive TLR signaling in
response to invasive microbes can exacerbate intestinal inflammation.24 The cytoplasmic
adaptor protein MyD88 transduces signals from TLRs that recognize bacterial products.78
The finding that Myd88-deficient mice exhibited increased susceptibility to chemicallyinduced colitis highlighted the importance of physiological TLR signaling for protection
of the epithelial barrier.157 Studies using bone marrow chimeras of Myd88-deficient and
wild-type mice in several mouse models of colitis demonstrated that MyD88 signaling in
hematopoietic cells was required for development of intestinal inflammation, whereas
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MyD88 signaling in non-hematopoietic cells was required for host survival.158,159 Here
we used cell type-specific deletion of the Myd88 gene to investigate the role of epithelialspecific MyD88 signaling in antibacterial immunity and protection against intestinal
inflammation.
Secretory immunoglobulin A (SIgA) acts as the first line of antigen-specific
immunity at the interface between the gut microbiota and the intestinal epithelium.47
Polymeric IgA secreted by plasma cells in the intestinal lamina propria is transported
across IECs by the polymeric immunoglobulin receptor (pIgR).160 Importantly, we found
that reduced expression of pIgR was correlated with greater disease severity in patients
with IBD60 and in mouse models of experimental colitis.161 Our finding that expression of
pIgR is regulated in IECs by Toll-like receptor signaling62 suggests that microbialepithelial cross-talk is crucial for optimal production of SIgA. Consistent with this
concept, we found that MyD88-deficient mice had reduced colonic expression of pIgR
and deficient transport of SIgA.160 However, in that study it was not determined whether
pIgR was regulated directly by MyD88 signaling in IECs or indirectly by immune cells in
the intestinal lamina propria. In the present study we used targeted deletion of the Myd88
gene to demonstrate an essential role for epithelial-specific MyD88 signaling in
maintaining optimal expression of pIgR and transport of SIgA.
The thick layer of intestinal mucus acts to separate luminal bacteria from the
epithelial surface.162 This mucus is rich in antimicrobial peptides163 and associates with
SIgA via glycan-mediated interactions,164 thus forming an immunological as well as a
physical barrier against microbial invasion. Here we report that targeted deletion of
MyD88 in IECs causes down-regulated expression of pIgR, mucin-2 (the major protein
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constituent of intestinal mucus) and antimicrobial peptides in IECs. We propose a model
in which MyD88-dependent bacterial-epithelial cross-talk is crucial for maintenance of
physical and immunological barrier function in the intestine.

Results
Loss of MyD88 signaling in colonic epithelial cells disturbs the segregation of
microbiota and host
To investigate the role of epithelial MyD88 signaling in intestinal homeostasis,
we generated mice with a targeted deletion of the Myd88 gene in intestinal epithelial cells
(MyD88∆IEC), by crossing mice carrying loxP-flanked Myd88 alleles (MyD88Flox) with
mice that express Cre recombinase under the control of the IEC-specific Vil1
promoter.165 Levels of MyD88 mRNA were significantly reduced in isolated colonic
epithelial cells (ECs) from MyD88∆IEC mice at 9 weeks of age (Figure 5-1a).
Immunostaining revealed expression of MyD88 in colonic epithelial cells (ECs) and
lamina propria mononuclear cells (LPMCs) of MyD88Flox mice, whereas MyD88∆IEC
mice lacked MyD88 expression in ECs but retained expression in LPMCs (Figure 5-1b).
Compared to MyD88Flox littermates, MyD88∆IEC mice showed no histological signs of
intestinal inflammation at 9 weeks of age (Figure 5-1b), or when followed up to 12
months (Figure 5-2). No pathological changes in colon morphology were observed.
Although there were no differences in numbers of culturable bacteria in feces from
MyD88Flox and MyD88∆IEC mice, we observed increased mucus-associated CFU in
MyD88∆IEC mice (Figure 5-1c). These differences were not restricted to culturable
bacteria, since similar trends where observed when using qRT-PCR of 16s rDNA to
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quantify bacterial numbers (Figure 5-3). Furthermore, increased bacterial attachment to
the epithelial surface in MyD88∆IEC mice was correlated with increased translocation of
bacteria to the draining mesenteric lymph nodes (MLNs) (Figure 5-1d, e). Interestingly,
about 25% of bacterial colonies cultured from MLNs of MyD88∆IEC mice had a large,
mucoid morphology and were identified as Klebsiella pneumoniae by sequencing of 16S
rRNA genes and biochemical tests (Figure 5-4). No bacteria could be cultured from the
spleens of MyD88∆IEC mice, suggesting that infection with gut-derived bacteria was
confined to the mucosal immune system. These findings indicate that epithelial-specific
MyD88 signaling is required for normal segregation of gut commensals from host tissues.

Loss of MyD88 signaling in colonic epithelial cells compromises epithelial barrier
function
We hypothesized that increased epithelial permeability in MyD88∆IEC mice,
coupled with increased numbers of mucus-adherent bacteria, could result in leakage of
bacteria into the lamina propria and travel via the lymphatics to MLNs. Measurement of
transmucosal electrical resistance (TER) in isolated colonic tissues revealed significant
decreases in MyD88∆IEC mice, indicative of decreased epithelial barrier function (Figure
5-5a). This ex vivo analysis was supported by the in vivo observation of elevated levels of
serum albumin in the feces of MyD88∆IEC mice, reflecting leakage of serum proteins into
the intestinal lumen (Figure 5-6). To determine whether increased mucosal adherence
and epithelial translocation of bacteria in MyD88∆IEC mice was selective for opportunistic
pathogens such as K. pneumoniae, we treated mice orally for 7 days with an
environmental, nonpathogenic strain of E. coli (Nissle 1917),166 which had been
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transformed to kanamycin resistance. We observed similar numbers of KanR E. coli in
feces and luminal washes from MyD88Flox and MyD88∆IEC mice, but significantly
increased numbers in the colonic mucus of MyD88∆IEC mice (Figure 5-5b), consistent
with the finding that mucus extracted from MyD88∆IEC mice had reduced antibacterial
activity compared to MyD88Flox mice (Figure 5-5c). However, these KanR E. coli did not
translocate to the MLNs of MyD88∆IEC mice (data not shown). These results suggested
that increased mucosal adherence of bacteria in MyD88∆IEC mice may be non-selective,
whereas translocation to the draining lymph nodes may be selective for more aggressive
bacteria such as K. pneumoniae.
We hypothesized that loss of epithelial MyD88 signaling could result in increased
bacterial invasion of IECs. To assess epithelial invasion independent of the confounding
effects of local immune cells, we performed in vitro bacterial invasion assays in the
human HT-29 colon carcinoma cell-line. We tested the effects of shRNA-mediated
knockdown of MyD88 (Figure 4-7 for shRNA knockdown of MyD88) on attachment
and invasion of three species of Gram-negative bacteria of the family
Enterobacteriaceae: the non-invasive E. coli strain Nissle 1917, the opportunistic
pathogen K. pneumoniae (a strain isolated from the MLN of a MyD88∆IEC mouse), and
the invasive pathogen Salmonella typhimurium (strain SL1344) (Figure 5-5d).
Knockdown of MyD88 expression in HT-29 cells resulted in significantly increased
adherence of all 3 bacterial species to the epithelial surface. As expected, the magnitude
of epithelial invasion by E. coli and K. pneumoniae was dramatically lower than was
observed for S. typhimurium, but invasion of all 3 species was significantly increased
when expression of MyD88 was reduced. Taken together, our findings suggest that
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MyD88 signaling in ECs plays a crucial role in intestinal immunity by increasing
antibacterial activity of epithelial mucus, reducing bacterial adherence to the epithelial
surface, maintaining epithelial barrier function, and preventing bacterial invasion of
epithelial cells.

Loss of MyD88 signaling in intestinal epithelial cells alters the composition of the
gut microbiota
We hypothesized that compromised innate immunity resulting from loss of
epithelial MyD88 signaling would affect the balance of the gut bacterial community,
resulting in an altered composition of the gut microbiota in MyD88∆IEC mice. The
richness and diversity of fecal bacteria was analyzed by the PhyloChipTM assay, a
microarray-based method that measures the relative abundance of more than 59,000
individual microbial taxa in fecal DNA by analysis of the entire 16S ribosomal RNA
gene sequence,108 in MyD88Flox and MyD88∆IEC mice. While the overall richness of the
fecal microbiota of MyD88Flox and MyD88∆IEC mice was similar (Figures 5-7 and 5-8),
significant differences were observed in the relative abundance of operational taxonomic
units (OTUs, defined as a group of highly similar 16S rRNA gene sequences, in most
cases with similarity > 99%) within several bacterial families (Figure 5-9). A large
proportion of families in the phylum Bacteroidetes were decreased in abundance in
MyD88∆IEC mice, whereas a large proportion of families in the phylum Proteobacteria
were increased. Within the phylum Firmicutes, the abundance of some families were
increased while others were decreased in MyD88∆IEC mice. Principal component analysis
(PCA), which was used to visualize complex relationships among multiple bacterial
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families in individual mice, revealed significant differences between MyD88Flox and
MyD88∆IEC mice (Figure 5-10a, left panel). Interestingly, the composition of the
microbiota was much more variable among individual MyD88Flox mice than among
individual MyD88∆IEC mice, as indicated by the tight clustering of the five MyD88∆IEC
mice in the 2-dimensional PCA plot. This result suggests that loss of epithelial MyD88
signaling may cause specific and reproducible changes in the bacterial community,
consistent with the finding that the abundance of 2647 OTUs differed significantly
between MyD88Flox and MyD88∆IEC mice (Figure 5-10a, right panel). The Prediction
Analysis for Microarrays (PAM) method111 was used to identify “distinctive” OTUs
whose relative abundance characterizes the unique microbiota of MyD88Flox and
MyD88∆IEC mice (Figure 5-10b). This analysis identified 4 distinctive OTUs in the TM7
candidate division that were characteristic of MyD88∆IEC mice, and 7 OTUs within the
genus Lactobacillus (phylum Firmicutes) that were characteristic of MyD88Flox mice.
Interestingly, the relative abundance of five bacterial species that have been associated
with altered innate and adaptive immunity in the gut, including Candidatus arthromitus
(SFB),167 Escherichia coli,77 Pseudomonas fluorescens, 77 Klebsiella pneumonia168 and
Proteus mirabilis,168 did not differ significantly in the fecal microbiota of MyD88Flox and
MyD88∆IEC mice (Figure 5-10c). This finding suggests that translocation of K.
pneumoniae to the MLNs of MyD88∆IEC mice (Figure 5-1e) was due to a specific defect
in the host response to this bacterium, and not simply to an increase in the abundance of
K. pneumoniae in the gut microbiota.
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Loss of MyD88 signaling in intestinal epithelial cells results in altered epithelial gene
expression and reduced transcytosis of IgA
To determine whether loss of epithelial MyD88 signaling resulted in altered
patterns of gene expression, we isolated colonic epithelial cells from MyD88Flox and
MyD88∆IEC mice and analyzed mRNA levels. 36 genes were chosen for mRNA analysis
based on our previous studies and other reports implicating these genes as targets of
MyD88 signaling, or having roles in epithelial cell function, innate immune signaling
and/or colonic inflammation (Table 5-2). These genes included: 5 signature biomarkers
that we have shown to be correlated with disease severity in human IBD and mouse
models of colitis (Pigr, Rela, Tnfaip3, Tnf, Cxcl2)161; Relb, which encodes the RELB
subunit of the alternative NF-κB signaling pathway, which we have shown to be
implicated in regulation of Pigr gene transcription105;Muc2, which encodes the major
colonic mucin protein, the loss of which is associated with spontaneous development of
colitis37; genes associated with epithelial homeostasis and barrier function (Areg158,
Bcl2l1169, Birc2170, Mmp3 and Mmp9171, Tcf4172, Mylk71 and Tjp1173); antimicrobial
peptides (Defa6163, Defa-rs1 [FE Johansen, personal communication], Reg3g42, Tff3174 );
genes involved in MyD88-dependent TLR signaling and protection against experimental
colitis (Myd88159,Tlr2175, Tlr4176, Tlr580); genes involved in intracellular immune
signaling (Smad7177, Stat3178); and a number of pro- and anti-inflammatory cytokines,
chemokines and biological mediators that have been implicated in protection against or
exacerbation of colitis (Ccl2179, Cxcl1179, Il10180, Il13181, Il18182, Il1b183, Il6157, Ptgs2184,
Tgfb1177, Tnfs13b45, Tslp185). Among these genes, five (including MyD88, as a positive
control) were down-regulated in MyD88∆IEC mice, and none were up-regulated (Figure
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5-11a). The most significantly down-regulated gene was the polymeric immunoglobulin
receptor (Pigr), the epithelial transporter for polymeric IgA antibodies. Immunostaining
of colon tissues revealed that expression of pIgR and co-localization with IgA were
severely down-regulated in epithelial cells of MyD88∆IEC mice (Figure 5-11b), and fecal
levels of IgA levels were significantly reduced (Figure 5-11c). Importantly, this
reduction in luminal IgA was similar to the reduction we previously reported in MyD88-/mice11, supporting a direct role for epithelial MyD88 signaling in regulating IgA
transcytosis. Consistent with these results, we confirmed a direct role for epithelial
MyD88 signaling in regulating pIgR expression by demonstrating that shRNA-mediated
knockdown of MyD88 expression in the human HT-29 colon carcinoma cell-line
significantly reduced the up-regulation of pIgR in response to bacterial stimulation
(Chapter 4, Figure 4-7). Other down-regulated genes included mucin-2 (Muc2), the
major protein constituent of intestinal mucus, and the antimicrobial peptides regenerating
islet-derived IIIγ (Reg3g) and defensin-α related sequence 1 (Defa-rs1). Although there
were no significant differences in goblet cell numbers in the colonic epithelia of
MyD88Flox and MyD88∆IEC mice (Figure 5-12), immunostaining revealed that the level
of mucin-2 protein per goblet cell was reduced in MyD88∆IEC mice (Figure 5-11d).
Down-regulation of RegIIIγ and Defa-rs1likely contributed to the reduced antimicrobial
activity of colonic mucus in MyD88∆IEC mice (Figure 5-5c). Interestingly, we found that
expression of many epithelial genes that have been previously been reported to be
regulated by MyD88 signaling, including Areg, IL-6, TLR4,and Ptgs2, was not altered in
MyD88∆IEC mice. It is possible that MyD88-dependent signaling from other cell types
may supply cues that regulate expression of these genes.
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Loss of MyD88 signaling in colonic epithelial cells results in increased susceptibility
to dextran sulfate sodium-induced colitis
Inappropriate inflammatory responses to normal components of the intestinal
microbiota are thought to play a major role in the pathogenesis of IBD.79,155,186 Although
we observed no overt inflammatory disease in MyD88∆IEC mice, they exhibited several
defects that have been reported in IBD patients, including reduced expression of pIgR,60
MUC2,187 and antimicrobial peptides163,188 as well as perturbed spatial relationships
between microbiota and host.42,69 To test the hypothesis that MyD88∆IEC mice are more
susceptible to experimental colitis, acute epithelial damage was induced by
administration of 2% dextran sulfate sodium (DSS) in the drinking water for 7 days.
MyD88∆IEC mice had significantly higher disease activity than did MyD88Flox mice,
beginning as early 1 day after initiation of DSS treatment (Figure 5-13a). At the
termination of the experiment, increased inflammatory cell infiltration and epithelial
destruction were observed in colons of MyD88∆IEC mice (Figure 5-13b,c). Surprisingly,
we did not detect expression of several genes that have previously been reported to be
produced by intestinal epithelial cells (Defa-6, Tnfsf13b, Il-13, Il-10, Tslp) in epithelial
cells from either MyD88∆IEC or MyD88Flox mice under normal or inflammatory
conditions (Table 5-2). Nineteen genes from a total of 36 were selected for principal
component analysis (PCA), based on ranking of P values for the comparison of mRNA
transcript levels in MyD88∆IEC and MyD88Flox mice, with and without DSS treatment (n
= 31) (Tables 5-2, 5-3 and 5-4). Factor analysis by the principal component method3
detected a significant relationship among the 19 transcripts (Χ2 = 816.7, p < 0.0001), and
reduced the data to 4 principal components (PCs) (Figure 5-14). PC1 and PC2 together
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accounted for 68.8% of the overall variance in gene expression, whereas PC3 and PC4
only contributed minimally (variance proportion < 0.1). Scores for PC1 and PC2 for each
individual mouse were calculated as the sum of normalized expression levels for each
gene multiplied by the corresponding coefficient for PC1 and PC2. This principal
component analysis of gene expression in colonic ECs following DSS treatment revealed
significantly different patterns in MyD88∆IEC and MyD88Flox mice (Figure 5-13d)
Expression of 10 genes was significantly down-regulated and expression of 5 genes was
up-regulated in colonic ECs from MyD88Flox mice following DSS treatment (Figure 513e, top panel). Interestingly, MyD88∆IEC mice were defective in their ability to upregulate the expression of the pro-inflammatory factors TNF, CXCL2 and IL-1β in
colonic ECs in response to DSS-induced damage (Figure 5-13e, bottom panel). Aberrant
up-regulation of the antimicrobial peptide Defa-rs1 in colonic ECs of MyD88∆IEC mice
may have been caused by increased microbial stimulation secondary to increased
epithelial damage in these mice. These findings suggest that lack of epithelial MyD88
expression causes specific defects in innate immune gene expression, resulting in a
compromised host response to epithelial injury and increased colonic inflammation.
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Protection against bacterial invasion and infection in the intestine is dependent on
the resident microbiota, the mucus layer containing SIgA and antimicrobial peptides, and
the monolayer of IECs that provide a physical and innate immune barrier154. Here we
demonstrated that loss of epithelial MyD88 signaling compromises antibacterial
immunity at all three layers of defense, resulting in translocation of bacteria to mesenteric
lymph nodes. Loss of MyD88 in IECs did not cause spontaneous colitis, but rendered
mice more susceptible to inflammation caused by the epithelial damaging agent DSS.
These findings demonstrate the critical role of epithelial MyD88 signaling in
maintenance of intestinal barrier function and protection against inflammation.
Unlike the inflammatory response generated by MyD88-dependent TLR signaling
in immune cells, IECs respond by producing factors involved in epithelial cell
proliferation, maintenance of barrier function, innate antimicrobial immunity and
transport of SIgA.160,6 Here we report that targeted deletion of the Myd88 gene in IECs
was associated with reduced expression of pIgR and epithelial transport of IgA, providing
direct evidence for the first time that epithelial MyD88 signaling regulates the production
of SIgA. These SIgA antibodies in turn modulate the composition of the gut microbiota
and form the first line of antigen-specific immunity that prevents invasion of IECs by
members of the gut microbiota.45 This connection between epithelial MyD88 signaling,
SIgA production and host-microbial homeostasis provides a potential explanation for our
previous findings that reduced pIgR expression and SIgA transport were correlated with
disease severity in human inflammatory bowel disease60 and in mouse models of
experimental colitis.161 We previously reported189 that expression of pIgR was up-
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regulated by TNF and IL-1β, the latter of which signals through a MyD88-dependent
pathway. 190 We found here that loss of epithelial MyD88 signaling was associated with
defective production of IL-1β and TNF in colonic ECs in response to DSS-induced
inflammation, suggesting that MyD88 may coordinate the response of IECs to autocrine
and paracrine stimulation with IL-1 and TNF, as well as TLR signaling.
The intestinal epithelium is protected by a mucus layer that increases in thickness
from the small to the large bowel in proportion to the density of the microbiota.36 In
addition to its role as a physical barrier, mucus serves to trap protective factors such as
SIgA and antimicrobial peptides.154, 191 We found that colonic ECs from MyD88∆IEC mice
produced significantly less Muc-2, antimicrobial peptides RegIIIγ and Defa-rs1, and
SIgA, consistent with reduced antimicrobial activity in colonic mucus. Vaishnava et al.42
recently reported that mice with a targeted deletion of MyD88 in IECs had reduced
expression of the antimicrobial peptide RegIII-γ in the terminal ileum, and increased
bacterial colonization of small intestinal surfaces. Gong et al.81 reported that mice
transgenic for an IEC-targeted, dominant-negative mutant of MyD88 had reduced
expression of antimicrobial peptides in the small intestine and increased bacterial
translocation to MLNs. MyD88 signaling may also provide cues to immune cells for
regulating the expression of antimicrobial and innate immune factors. Ismail et al.192
found that expression of RegIII-γ in small intestinal γδ intraepithelial lymphocytes (IELs)
was dependent on epithelial-specific MyD88 signaling, but not on expression of MyD88
within the IELs themselves. Thus epithelial MyD88 signaling provides direct and indirect
signals to augment production of antimicrobial factors that segregate the microbiota from
host tissues.
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In our studies, a hallmark of epithelial-specific MyD88 deficiency was
translocation of bacteria to the draining MLNs, including the opportunistic pathogen
Klebsiella pneumoniae. This Gram-negative bacterium of the family Enterobacteriaceae
is commonly found among the resident gut bacteria in both humans and mice, but has
limited invasive potential in healthy individuals.193 Although the defect in epithelial
barrier function in MyD88∆IEC mice may have contributed to paracellular leakage of
bacteria into the lamina propria, we did not observe translocation of commensal E. coli
to the MLNs of MyD88∆IEC mice, even though these bacteria colonized the mucus layer
of the colon. We conclude that virulence factors expressed by K. pneumoniae, but not by
commensal E. coli, may be required for survival during transit from the mucosal surface
to the MLNs. In contrast, Fukata et al.77 reported translocation of E. coli to the MLNs in
mice deficient in MyD88 in all cell types. MyD88-deficient mice have been shown to be
highly susceptible to systemic infections with a broad range of bacteria.194 Intratracheal
infection of MyD88-deficient mice with K. pneumoniae resulted in severe pneumonia,
attenuated neutrophil influx, and systemic dissemination of bacteria.195 Rare cases of
autosomal recessive MyD88 deficiency in humans were found to be associated with
recurrent life-threatening infections with pyogenic bacteria early in life,194 including an
acute urinary tract infection caused by K. pneumoniae in a 4 month-old boy. However,
we did not observe systemic bacterial infections in MyD88∆IEC mice. We conclude that
epithelial MyD88 signaling is required for preventing the translocation of K. pneumoniae
and possibly other opportunistic pathogens to the MLNs, but that MyD88-sufficient
immune cells can prevent the systemic spread of resident gut bacteria that have
penetrated the mucosal barrier.
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Our findings have revealed for the first time a unique role for epithelial MyD88
signaling in shaping the composition of the resident gut microbiota, including increased
numbers of OTUs in the phylum Proteobacteria and decreased numbers of OTUs within
the phylum Bacteroidetes in MyD88∆IEC mice. Interestingly, similar changes in the
composition of the gut microbiota have been observed in human IBD patients.196 Altered
host factors that are believed to impact commensal bacteria in IBD patients include
increased intestinal permeability, decreased production of antimicrobial peptides and
aberrant SIgA responses,196 all of which characterize the immune defects in mice with a
targeted deletion of MyD88 in IECs. In addition to changes at the level of bacterial phyla
and families, the Prediction Analysis for Microarrays technique identified 4 “signature”
OTUs in the candidate division TM7, whose increased abundance was characteristic of
the altered microbiota of MyD88∆IEC mice. Importantly, increased abundance of TM7
bacteria have been reported in humans with oral inflammation197 and IBD.198 Increased
abundance of TM7 bacteria has been reported in the gut microbiota of mice deficient in
the NLRP6 inflammasome, accompanied by the development of spontaneous intestinal
inflammation and increased susceptibility to DSS-induced colitis.182 Reduced production
of IL-18, which transduces signals through MyD88, was characteristic of NLRP6deficient mice. Thus impaired MyD88 signaling in the intestine may alter the local
microenvironment to favor expansion of TM7. In contrast, we did not observe changes in
the gut microbiota of MyD88∆IEC mice that have been associated with other mouse
models of intestinal inflammation caused by defects in immune cells, such as increased
abundance of Gram-positive segmented filamentous bacteria (Candidatus arthromitus),
which have been implicated in the expansion of Th17 cells and inflammation of the gut

111

and extraintestinal tissues167. Neither did we observe expansion of Proteus mirabilis nor
Klebsiella pneumoniae, two Gram-negative species of the family Enterobacteriaceae, the
abundance of which was increased in the gut microbiota of mice with defective immunity
in dendritic cells in the intestinal lamina propria.168 Increased colonization with
Enterobacteriaceae and elevated titers of Enterobacteriaceal antibodies have been
associated with IBD in humans,199 and species of the genus Klebsiella are observed more
frequently in the stool of ulcerative colitis patients than healthy controls.200 Our finding
of unique changes in the gut microbiota of MyD88∆IEC mice suggests that epithelial
MyD88 signaling is required to protect against abnormal expansion of specific members
of the gut microbial community.
Although loss of epithelial MyD88 signaling was not sufficient to cause
spontaneous intestinal inflammation for at least one year of life, it was associated with
increased severity of colitis following oral administration of the epithelial damaging
agent, DSS. A potential mechanism for the increased susceptibility to DSS-induced
colitis was suggested by our observation that MyD88∆IEC mice failed to up-regulate
expression of TNF, CXCL2 and IL-1β in colonic ECs in response to epithelial damage.
This finding was somewhat surprising, considering that these factors are generally
considered to be pro-inflammatory and their increased expression has been linked to
increased disease severity in experimental colitis.157 Our data are consistent with the
notion that “physiological” inflammatory responses by IECs are a normal response to the
continuous presence of the gut microbiota, and are necessary for repair of damaged
epithelial cells. On the other hand, massive infiltration of gut microbes into the intestinal
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DISCUSSION
Protection against bacterial invasion and infection in the intestine is dependent on
the resident microbiota, the mucus layer containing SIgA and antimicrobial peptides, and
the monolayer of IECs that provide a physical and innate immune barrier154. Here we
demonstrated that loss of epithelial MyD88 signaling compromises antibacterial
immunity at all three layers of defense, resulting in translocation of bacteria to mesenteric
lymph nodes. Loss of MyD88 in IECs did not cause spontaneous colitis, but rendered
mice more susceptible to inflammation caused by the epithelial damaging agent DSS.
These findings demonstrate the critical role of epithelial MyD88 signaling in
maintenance of intestinal barrier function and protection against inflammation.
Unlike the inflammatory response generated by MyD88-dependent TLR signaling
in immune cells, IECs respond by producing factors involved in epithelial cell
proliferation, maintenance of barrier function, innate antimicrobial immunity and
transport of SIgA.160,6 Here we report that targeted deletion of the Myd88 gene in IECs
was associated with reduced expression of pIgR and epithelial transport of IgA, providing
direct evidence for the first time that epithelial MyD88 signaling regulates the production
of SIgA. These SIgA antibodies in turn modulate the composition of the gut microbiota
and form the first line of antigen-specific immunity that prevents invasion of IECs by
members of the gut microbiota.45 This connection between epithelial MyD88 signaling,
SIgA production and host-microbial homeostasis provides a potential explanation for our
previous findings that reduced pIgR expression and SIgA transport were correlated with
disease severity in human inflammatory bowel disease60 and in mouse models of
experimental colitis.161 We previously reported189 that expression of pIgR was up-
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Figure 5-1 Targeted deletion of MyD88 in intestinal epithelial cells results in
increased numbers of mucus-associated bacteria and bacterial translocation to
mesenteric lymph nodes. (a) Mice with a targeted deletion of the Myd88 gene in
intestinal epithelial cells (IEC) (MyD88IEC) were created by crossing mice in which both
copies of the MyD88 gene were flanked with loxP sites (MyD88Flox) with mice
expressing Cre recombinase under the control of the IEC-specific Vil1 promoter.
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Figure 5-1 (continued) Levels of MyD88 mRNA were analyzed in colonic epithelial
cells isolated from 9 week-old littermate MyD88Flox and MyD88IEC mice by Nanostring
nCounterTM hybridization. mRNA transcript abundance was normalized as described in
Materials and Methods, and expressed as mean ± SEM (n=15). (b) Colon tissue sections
from MyD88Flox and MyD88IEC mice were stained with hematoxylin and eosin (upper
panels) or FITC-labeled antibodies to MyD88 (green) and the nuclear stain DAPI (blue)
(lower panels). (c) Bacterial colony-forming units (CFU) were enumerated following
anaerobic culture of fecal homogenates (CFU/g feces), luminal washes (CFU/ml PBS),
and surface mucus (CFU/100l mucus) from colons of MyD88Flox and MyD88IEC mice.
Data are expressed as mean ± SEM (n = 6). (d) Bacterial colonies cultured under
anaerobic conditions from mesenteric lymph nodes (MLNs) of representative MyD88Flox
and MyD88IEC mice. Large mucoid colonies from MyD88IEC mice were identified as
Klebsiella pneumoniae by sequence analysis of 16S rRNA genes and biochemical tests
(Figure 5-3). (e) CFU of total anaerobic bacteria and K. pneumoniae cultured from
MLNs of MyD88Flox and MyD88IEC mice. Data in the bar graph are expressed as CFU
per MLN (mean ± SEM, n = 27). The numbers below the bar graph indicate the
percentage of mice of each genotype from which bacteria (total and K. pneumoniae)
could be cultured from MLNs. In all panels, asterisks indicate that the mean for
MyD88IEC mice is significantly different from the mean for MyD88Flox mice (p < 0.05).
(Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results in
compromised antibacterial immunity associated with the down-regulation of polymeric
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in
press 2012) Reprinted with permission.
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Figure 5-2 MyD88∆IEC mice do not develop spontaneous colitis with age. Colon
histology from representative mice at 6, 9 and 12 months of age. Images of formalinfixed colon tissues stained with hematoxylin and eosin were captured with a 20X
objective. (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results
in compromised antibacterial immunity associated with the down-regulation of polymeric
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in
press 2012) Reprinted with permission
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Figure 5-3. Quantification of bacteria in colonic niches of MyD88Flox and MyD88∆IEC
mice. Bacterial 16sRNA was quantified by qRT-PCR from fecal homogenates (CFU/g
feces), luminal washes (CFU/ml PBS), and surface mucus (CFU/100 ml mucus) from
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Figure 5-3 (continued) MyD88Flox and MyD88IEC mice. Data are expressed as mean ±
SEM (n = 5). (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells
results in compromised antibacterial immunity associated with the down-regulation of
polymeric immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal
Immunology,in press 2012) Reprinted with permission.
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Figure 5-4 Identification of Klebsiella pneumoniae in the mesenteric lymph nodes
(MLN) of MyD88∆IEC mice. (a) Sequence of the 16S rRNA gene amplified from mucoid
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Figure 5-4 (continued) bacterial colonies isolated from MLNs of MyD88IEC mice.
Identical sequences were obtained from colonies isolated from 2 different MyD88IEC
mice. (b) BLAST alignments of the unknown 16S rRNA sequence with known bacterial
genome sequences in the National Center for Biotechnology Information database.
Alignments are shown for 5 Klebsiella pneumoniae strains and 3 Escherichia coli strains
with at least 98% query coverage, ranked by maximum alignment score. (c) Biochemical
tests used to differentiate Klebsiella pneumonia from other Klebsiella species and
Escherichia coli. Two different clones isolated from MLNs of different MyD88IEC mice
and Escherichia coli strain Nissle1917 were tested and compared to expected results.
(Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results in
compromised antibacterial immunity associated with the down-regulation of polymeric
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in
press 2012) Reprinted with permission.
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Figure 5-5 Loss of MyD88 expression in intestinal epithelial cells compromises
epithelial barrier integrity. (a) Epithelial barrier function. Transmucosal electrical
resistance (TER) was analyzed ex vivo in isolated mouse colon tissues placed in Ussing
chambers. Data are expressed as a mean ± SEM (n = 8). (b) Association of exogenous,
noninvasive bacteria with colonic mucus. MyD88Flox and MyD88∆IEC mice were
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Figure 5-5 (continued) administered E. coli strain Nissle 1917 that had been transformed
to kanamycin resistance (KanR E. coli) at a dose of 2.5 x 107 CFU/ml in the drinking
water for 7 days. Kanamycin-resistant colonies were enumerated after anaerobic culture
of fecal homogenates (CFU/g feces), luminal washes (CFU/ml PBS), and epithelialassociated mucus (CFU/100l mucus). Data are expressed as mean ± SEM (n= 6).
(c) Antibacterial activity of colonic mucus. Aliquots of mucus harvested from the colons
of MyD88Flox and MyD88IEC mice were incubated for 15 min with 106 CFU of KanR E.
coli, then cultured in the presence of kanamycin to enumerate surviving E. coli. Data are
expressed as mean ± SEM (n = 6). (d) In vitro bacterial invasion assays. Clones of the
HT-29 human colon carcinoma cell-line were stably transfected with shRNA specific for
MyD88 or a random control sequence. Cell monolayers (2 cm2) were incubated with 106
CFU (MOI of 10:1) of E. coli strain Nissle 1917, a strain of K. pneumoniae isolated from
MLNs of MyD88IEC mice, or Salmonella typhimurium strain SL1344. Membrane-bound
CFU were enumerated by anaerobic culture of cell homogenates after washing to remove
unbound bacteria, and intracellular CFU were enumerated in parallel plates after 2 hours
of treatment of cell monolayers with gentamicin to kill all extracellular bacteria. Data are
expressed as mean ± SEM (n = 6). Asterisks indicate that the mean for MyD88IEC mice
is significantly different from the mean for MyD88Flox mice (panels a-c) or that the mean
for cells expressing MyD88 shRNA is significantly different from the mean for cells
expressing control shRNA (panel d) (p < 0.05). (Frantz et al. Targeted deletion of
MyD88 in intestinal epithelial cells results in compromised antibacterial immunity
associated with the down-regulation of polymeric immunoglobulin receptor, mucin-2 and
antibacterial peptides. Mucosal Immunology,in press 2012) Reprinted with permission.
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Figure 5-6 Fecal Albumin levels in MyD88∆IEC. Feces were collected from 10 week old
MyD88Flox and MyD88∆IEC mice and serum albumin levels were determined by ELISA.
Data are expressed as mean ± SEM (n = 5). (Frantz et al. Targeted deletion of MyD88 in
intestinal epithelial cells results in compromised antibacterial immunity associated with
the down-regulation of polymeric immunoglobulin receptor, mucin-2 and antibacterial
peptides. Mucosal Immunology,in press 2012) Reprinted with permission.
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Figure 5-7 Archaeal (green) and bacterial (blue) subfamily richness in individual
MyD88Flox and MyD88∆IEC mice. Each bar represents an individual mouse. The Y axes
indicate the number of distinct bacterial or archaeal subfamilies indentified in fecal DNA
from each mouse, based on taxonomic classification of 16S rRNA sequences. (Frantz et
al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised
antibacterial immunity associated with the down-regulation of polymeric
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in
press 2012) Reprinted with permission.
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Figure 5-8 Proportions of operational taxonomic units (OTUs) classified at the
family rank in fecal DNA from MyD88∆IEC and MyD88Flox mice. Each bar represents
an individual mouse. The size of each color block represents the number of detected
OTUs in that family relative to the total number of OTUs detected in fecal DNA from
that mouse. (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results
in compromised antibacterial immunity associated with the down-regulation of polymeric
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in
press 2012) Reprinted with permission.
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Figure 5-9 Differences in the composition of the fecal microbiota of MyD88Flox and
MyD88∆IEC mice. The relative abundance of operational taxonomic units (OTUs) was
quantified by PhylochipTM microarray analysis of 16S rRNA gene sequences in fecal
DNA from 4 MyD88Flox and 5 MyD88∆IEC littermate mice (see Methods for details of
data analysis). A representative 16S rRNA gene from each of 109 differentially expressed
OTUs was aligned and used to infer the phylogenetic tree shown in this figure. The rings
around the tree comprise a heatmap where the inner ring includes the samples from
MyD88Flox mice, and the outer ring includes the samples from MyD88∆IEC mice. Blue
lines indicate that the OTU was more abundant in that sample than in the mean of
MyD88Flox mice samples, and red lines indicate that the OTU was less abundant. The
color saturation indicates the fold difference in OTU abundance for each mouse
compared to the mean for MyD88Flox mice. (Frantz et al. Targeted deletion of MyD88 in
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Figure 5-9 (continued) intestinal epithelial cells results in compromised antibacterial
immunity associated with the down-regulation of polymeric immunoglobulin receptor,
mucin-2 and antibacterial peptides. Mucosal Immunology,in press 2012) Reprinted with
permission.
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Figure 5-10 Loss of MyD88 expression in intestinal epithelial cells is associated with
changes in the composition of the fecal microbiota. (a) Principal component analysis
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Figure 5-10 (continued) (PCA) was used to generate two-dimensional ordination plots
that visualize complex relationships between the fecal microbiota of individual
MyD88Flox and MyD88IEC mice, based on weighted Unifrac distances between OTUs
detected in fecal samples. The graph on the left is based on 14193 OTUs present in at
least one mouse, and the graph on the right is based on 2647 OTUs with significant
differences in abundance between MyD88Flox and MyD88IEC mice. (c) Significant OTUs
that characterize the distinctive microbiota of MyD88Flox and MyD88IEC mice were
identified using the Prediction Analysis for Microarrays (PAM) method. Data in the bar
graph are expressed as fold difference (log2, mean ± SEM) in abundance between
MyD88IEC (n = 5) and MyD88Flox mice (n = 4). Bars to the right of the zero line
represent distinctive OTUs that were more abundant in MyD88IEC mice, all of which
were classified in the candidate phylum TM7. Bars to the left represent distinctive OTUs
that were more abundant in MyD88Flox mice, all of which were classified in the genus
Lactobacillus (phylum Firmicutes). Numbers in parentheses on the Y-axis are the IDs for
individual OTUs (see Table 5-1 for complete taxonomy of the distinctive OTUs). (d)
Relative abundance of 5 species of fecal bacteria in individual MyD88Flox and MyD88IEC
mice. Because each of these species (except Candidatus arthromitus) comprised multiple
OTUs, the OTU which represented the biggest difference in abundance between
MyD88Flox and MyD88IEC mice is displayed. (Frantz et al. Targeted deletion of MyD88
in intestinal epithelial cells results in compromised antibacterial immunity associated
with the down-regulation of polymeric immunoglobulin receptor, mucin-2 and
antibacterial peptides. Mucosal Immunology,in press 2012) Reprinted with permission.
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Table 5-1 Taxonomic annotations of operational taxonomic units (OTUs) with
significant differences in abundance between MyD88Flox and MyD88∆IEC mice.
Distinctive OTUs were identified by predictive analysis microarrays (see Figure 5-10c).
(Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results in
compromised antibacterial immunity associated with the down-regulation of polymeric
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in
press 2012) Reprinted with permission.
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Table 5-2 Gene expression in colonic epithelial cells from MyD88Flox and MyD88∆IEC
mice. Colonic epithelial cells were isolated from 9 week-old mice . Relative levels of 36
individual mRNA transcripts were analyzed by Nanostring nCounterTM hybridization and
normalized to 4 housekeeping genes. B.D., below detection. (Frantz et al. Targeted
deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial
immunity associated with the down-regulation of polymeric immunoglobulin receptor,
mucin-2 and antibacterial peptides. Mucosal Immunology,in press 2012) Reprinted with
permission.
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Table 5-3 DSS-induced changes in gene expression in colonic epithelial cells from
MyD88Flox mice. Mice (8 weeks of age) were given 2% DSS or regular drinking water
for 7 days prior to isolation of colonic epithelial cells. Relative levels of 36 individual
mRNA transcripts were analyzed by Nanostring nCounterTM hybridization and
normalized to 4 housekeeping genes. B.D., below detection. (Frantz et al. Targeted
deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial
immunity associated with the down-regulation of polymeric immunoglobulin receptor,
mucin-2 and antibacterial peptides. Mucosal Immunology,in press 2012) Reprinted with
permission.
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Table 5-4 Differences in DSS-induced changes in gene expression in colonic
epithelial cells from MyD88Flox and MyD88∆IEC mice. Mice (8 weeks of age) were
given 2% DSS in the drinking water for 7 days prior to isolation of colonic epithelial
cells. Relative levels of 36 individual mRNA transcripts were analyzed by Nanostring
nCounterTM hybridization and normalized to 4 housekeeping genes. B.D., below
detection. (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results in
compromised antibacterial immunity associated with the down-regulation of polymeric
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in
press 2012) Reprinted with permission.
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Figure 5-11. Loss of MyD88 expression alters epithelial gene expression and
compromises pIgR-mediated IgA transport. (a) Colonic epithelial cells were isolated
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Figure 5-11 (continued) from 8 week-old MyD88IEC and MyD88Flox mice (n = 12).
Levels of 36 individual mRNA transcripts were analyzed by Nanostring nCounterTM
hybridization and plotted as mean fold difference (log2) between MyD88IEC and
MyD88Flox mice vs. P-value (-log10). mRNA transcript levels for genes above the red
dashed line were significantly different in MyD88IEC mice compared to MyD88Flox mice
(p < 0.05). Genes to the left of the zero line were down-regulated, while genes to the right
were up-regulated. (b) Immunofluorescence staining of colon tissues from 9 week-old
MyD88Flox and MyD88IEC mice (pIgR = red, IgA = green, DAPI-stained nuclei = blue).
(c) Feces were collected from 10 week old MyD88Flox and MyD88IEC mice and IgA
levels were determined by ELISA. The asterisk indicate that the mean for MyD88IEC
mice is significantly different from the mean for MyD88Flox mice (p<0.05). Data are
expressed as mean ± SEM (n = 5). (d) Immunofluorescence staining of colon tissues
from 9 week-old MyD88Flox and MyD88IEC mice (Muc2 = red, DAPI-stained nuclei =
blue). (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results in
compromised antibacterial immunity associated with the down-regulation of polymeric
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in
press 2012) Reprinted with permission.
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Figure 5-12. Loss of epithelial MyD88 expression does not affect goblet cell numbers
in the colon. Images of formalin-fixed colon tissues from representative 10 week old
mice, stained with hematoxylin and eosin, were captured with a 40X objective. (Frantz et
al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised
antibacterial immunity associated with the down-regulation of polymeric
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in
press 2012) Reprinted with permission.
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Figure 5-13. Loss of MyD88 expression in intestinal epithelial cells increases the
severity of DSS-induced colitis. (a) Disease activity in MyD88Flox and MyD88IEC mice
given regular drinking water or 2% DSS for 7 days. Data are expressed as mean ± SEM
(n = 8). One asterisk indicates that the mean for DSS-treated mice is significantly greater
than the corresponding mean for untreated mice, and two asterisks indicate that the mean
for DSS-treated MyD88IEC mice is greater than the mean for DSS-treated MyD88Flox
mice. (b) Colon histology from representative mice at day 7. Images of
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Figure 5-13 (continued) formalin-fixed colon tissues stained with hematoxylin and eosin
were captured with a 20X objective. (c) Histological inflammatory scores for MyD88Flox
and MyD88IEC mice on day 7 days. The asterisk indicate that the means for DSS-treated
mice are significantly different from the means for untreated mice of the same genotype,
and that the mean for MyD88IEC mice is significantly different from the mean for
MyD88Flox mice (p<0.05). Data are expressed as mean ± SEM (n = 8). (d) Principal
component analysis was used to generate two-dimensional ordination plots that visualize
complex relationships in expression of multiple genes in colonic EC of individual
MyD88Flox and MyD88IEC mice, with or without DSS treatment. Normalized mRNA
transcript levels for 19 genes were reduced to 2 PCs (see Figure 5-15 for details), which
are plotted for individual mice. (e) Levels of 36 individual mRNA transcripts were
measured by Nanostring nCounterTM hybridization. Data are plotted as mean fold
difference (log2) between MyD88Flox mice with or without DSS treatment vs. P-value (log10) (upper panel), and mean fold difference (log2) between DSS-treated MyD88IEC
and MyD88Flox mice vs. P-value (-log10) (lower panel). Individual dots represent the mean
of treatment groups (n = 8). mRNA transcript levels for genes above the red dashed line
were significantly different for each comparison (p < 0.05). Genes above the red dashed
line were significantly different in DSS-treated mice compared to untreated mice
(p<0.05). Genes to the left of the zero line were down-regulated, and genes to the right
were up-regulated. (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells
results in compromised antibacterial immunity associated with the down-regulation of
Figure 5-13 (continued) polymeric immunoglobulin receptor, mucin-2 and antibacterial
peptides. Mucosal Immunology,in press 2012) Reprinted with permission.
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Figure 5-14. Principal component analysis (PCA) of gene expression in colonic
epithelial cells from MyD88∆IEC and MyD88Flox mice in the presence and absence of
DSS treatment (a) Nineteen genes from a total of 36 were selected for PCA, based on
ranking of P values for the comparison of mRNA transcript levels in MyD88∆IEC and
MyD88Flox mice, with and without DSS treatment (n = 31) (see Tables 5-2, 5-3 and 5-4).
Data for mRNA transcript levels from individual mice were reduced to two principal
components that accounted for 68.8% of the overall variance in gene expression (PC1
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Figure 5-14 (continued) and PC2). Weighted coefficients are listed for each variable
comprising PC1 and PC2. (b) PC1 and PC2 scores were calculated for each individual
mouse as the sum of normalized expression levels for each gene multiplied by the
corresponding coefficient for PC1 and PC2. Bar graphs indicate the mean + SEM for
each treatment group (n = 7-9). Asterisks indicate that the mean for DSS-treated mice is
significantly different from the mean for untreated mice of the same genotype (p < 0.05).
P-values for the comparisons between DSS-treated MyD88Flox and MyD88IEC mice are
noted on the graph. (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells
results in compromised antibacterial immunity associated with the down-regulation of
polymeric immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal
Immunology,in press 2012) Reprinted with permission.

Copyright © Aubrey L. Frantz 2012

142

Chapter Six – Discussion and Future Directions

Maintenance of pIgR expression is required for intestinal homeostasis
An important finding in this work is that the downregulation of pIgR expression
that is observed in patients with IBD, is also a common feature in mouse models of acute
and chronic experimental colitis. Notably, this downregulation in epithelial gene
expression is correlated with disease severity. These results raise the question of whether
dysregulation of pIgR expression is a cause or consequence of intestinal inflammation. It
is possible that inflammation-induced damage to the intestinal epithelium may disrupt
intracellular signaling pathways and alter protein trafficking, leading to the dysregulation
of pIgR expression. For example, chronic inflammation has been shown to reduce the
activity of critical chaperone proteins required for proper protein trafficking, resulting in
loss of epithelial polarity201. Loss of epithelial polarity leads to dysregulation of pIgR
expression and transport of IgA44. Thus, independent of the mechanism by which
intestinal inflammation develops, pIgR expression is significantly impaired. We found
that this defect is associated with dysregulated epithelial transcytosis of IgA, reduced
levels of luminal SIgA, accumulation of IgA in the intestinal lamina propria, as well as
increased levels of circulating IgA. Multiple studies suggest that reduced transport of
SIgA exacerbates intestinal inflammation. pIgR deficient mice, which have significantly
reduced SIgA in external secretions, were found to be more susceptible than wild-type
mice to acute DSS-induced colitis58. Furthermore, pIgR deficient mice are more
susceptible to a variety of bacterial infections202-204. Taken together, it can be concluded
that maintaining high levels of pIgR expression is necessary to maintain intestinal
homeostasis.
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Not only does maintaining high levels of pIgR expression maintain sufficient
transcytosis of SIgA, but it also provides sufficient levels of free SC in the intestinal
lumen. The SC moiety of SIgA has also been shown to contribute to innate defense
mechanisms, including prevention of bacterial adherence to the intestinal mucus layer
and neutralization of potential pro-inflammatory factors 54,134. However, the work
presented here suggests that expression of pIgR and transport of free SC has a role in
protection against intestinal inflammation. Since Rag-\- mice do not produce IgA, any
protective effects of T regulatory cells in this model do not involve maintaining IgA
function. Interestingly, we found that in mice that received T effector and T regulatory
cells, pIgR expression was restored to a level that was not significantly different than
control mice. Accordingly, weight loss, colon weight to length ratio and PC values for
mice who received T effectors and T regulatory cells were no different than control mice.
Thus, restoration of pIgR expression, independent of IgA, is associated with colitis
prevention. It has recently been reported that anti-TNF therapy not only neutralizes TNF,
but promotes the activation and expansion of T regulatory cells in CD patients 137.
Accordingly, maintaining an environment that promotes pIgR expression in epithelial
cells could be an additional mechanism by which T regulatory cells protect against T cell
dependent intestinal inflammation and restore intestinal homeostasis.
Overall these results suggest that therapeutic strategies aimed to maintain pIgR
expression may be beneficial. Recently, probiotics, defined as live microorganisms that
when administered in adequate amounts confer a health benefit on the host, are receiving
increasing attention as potential treatment options for intestinal inflammation. However,
the mechanisms by which probiotics achieve their beneficial effects remain unclear.
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Interestingly, E. coli strain Nissle 1917 (EcN) is the best characterized probiotic strain of
E.coli. EcN has been tested as a treatment for IBD in several clinical trials, and has been
shown to be as effective as mesalazine in maintaining remission in ulcerative colitis
patients166. In vitro experiments with cultured IEC have revealed several mechanisms by
which EcN may act, including induction of tight junction proteins, maintenance of barrier
function, inhibition of invasion by invasive bacteria, induction of antimicrobial βdefensins and chemokine synthesis, and inhibition of TNF induced pro-inflammatory
response205-207. Our lab has shown that EcN was unique among representative species of
the four major phyla of human colonic bacteria in its ability to upregulate expression of
pIgR in HT-29 cells62. Here we show that the induction of pIgR by EcN is mediated by
the TLR4-MyD88 dependent activation of NF-κB. In particular, this response is
primarily mediated by the classical RelA-dependent pathway, but the alternative RelBdependent pathway can compensate if necessary to maintain pIgR expression. Previous
work has demonstrated that bacterial-dependent MyD88 signaling by IECs promotes B
cell recruitment and IgA class-switching in the lamina propria4,19. Accordingly, the
induction and maintenance of high levels of pIgR expression, as well as enhanced IgA
production, resulting in increased transport of SIgA and SC, may be an additional novel
mechanism by which EcN achieves its probiotic effects. These results provide evidence
for the continued investigation and the therapeutic use of EcN as a probiotic treatment.

Epithelial MyD88 signaling in the colon
A primary goal of this work was to understand the role of intestinal epithelial
MyD88 signaling. The generation of mice with an epithelial-specific deletion of the
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Myd88 gene is a relatively new model. Vaishnava et al.42 recently reported that
MyD88∆IEC mice had reduced expression of the antimicrobial peptide RegIII-γ in the
terminal ileum and increased bacterial colonization of small intestinal surfaces. These
authors concluded that epithelial MyD88 regulation of RegIII-γ, which has specificity for
Gram-positive bacteria, is a mechanism to restrict numbers of mucus-associated Grampositive bacteria in specific niches of the intestine. Consistent with these results, we show
that RegIII-γ expression is reduced in the colon of MyD88∆IEC mice and extend these
findings to show that the antimicrobial peptide Defa-rs1, which is constitutively
expressed by IECs and upregulated in response to bacterial stimulation208, is also reduced
in the colons of MyD88∆IEC mice. These defects are associated with reduced
antimicrobial activity of colonic mucus, resulting in increased mucus-associated bacteria
in the colon, similar to published results in the small intestine42. However, we show that
MyD88∆IEC mice also have reduced expression of Muc-2 and pIgR (associated with
reduced transcytosis of IgA), which was not observed by Vaishnava et al. in the small
intestine of MyD88∆IEC mice. These discrepancies could be due to the structural and
functional differences of these organs. It is logical to assume that the colon, which houses
exponentially greater numbers of commensal bacteria than the small intestine, has
evolved mechanisms to efficiently regulate expression of antimicrobial and innate
immune genes to effectively deal with this huge bacterial load. Accordingly, our results
support the idea that in the colon, antimicrobial peptides, with specificities for both
Gram-positive and Gram-negative bacteria, as well as critical genes associated with
epithelial barrier function and immunity (Muc-2 and pIgR) are regulated by commensal
bacteria themselves. Thus, a feed-back system is established in which commensal
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bacteria induce the expression, via epithelial MyD88 signaling, of epithelial genes
required to maintain epithelial barrier function and homeostasis in the colon. In this
situation, the function of colonic epithelial MyD88 signaling is unique compared to other
cell types and locations.

Novel role of epithelial MyD88 signaling in regulating pIgR expression
Interestingly, pIgR was the most significantly downregulated gene in isolated
epithelial cells from MyD88∆IEC mice. Furthermore, this downregulation of pIgR
expression was associated with reduced transcytosis of SIgA and reduced levels of IgA in
the feces of MyD88∆IEC mice. While it has been suggested that MyD88 signaling in
epithelial cells regulates the expression of several genes necessary to maintain
homeostasis6,78, this is the first study to demonstrate that epithelial MyD88 signaling is
required to maintain sufficient pIgR expression and SIgA transcytosis in vivo. Our lab
previously showed that pIgR expression and IgA transport was reduced in MyD88
deficient mice160, but that study did not determine whether pIgR was regulated directly by
MyD88 signaling in IECs or indirectly by immune cells in the intestinal lamina propria.
While these new findings do not exclude the possibility that epithelial MyD88 signaling
provides immune cells with signals that regulate the production of SIgA, these results do
indicate that epithelial MyD88 signaling is necessary to regulate the expression of pIgR
and transport of IgA. Accordingly, it would be interesting to examine pIgR expression
and IgA transport in mice with myeloid-specific deletion of MyD88. Several studies had
revealed an essential role for dendritic cell MyD88 signaling in luminal sampling and the
induction of B cell differentiation in to IgA+ plasma cells6,209,210. Using bone-marrow
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chimeras it has been demonstrated that MyD88 signaling in myeloid cells mediates
susceptibility to chronic intestinal inflammation6. It would be hypothesized that while
pIgR expression may be slightly reduced in mice with MyD88-sufficient epithelial cells
and MyD88-deficient myeloid cells, the production of IgA would be significantly altered;
thus, dysregulated SIgA responses may also contribute to disease in this model.
This work also reveals a novel role of epithelial NF-κB signaling, downstream of
MyD88, in maintaining pIgR expression in response to commensal bacteria. While proinflammatory responses to commensal bacteria are dependent on the classical RelA
pathway, both the classical and alternative NF-κB pathways can induce pIgR expression.
By utilizing signaling pathways that are distinct from those involved in regulating proinflammatory responses, it is possible that IECs are able to upregulate pIgR expression in
response to microbial and host stimuli while suppressing a potentially damaging proinflammatory response. Taken together, these results suggest that the regulation of pIgR
expression in IECs may be an important mechanism by which MyD88-dependent
activation of NF-κB maintains intestinal homeostasis. Consistent with this idea, we found
that loss of intestinal homeostasis associated with experimental colitis and human IBD is
generally accompanied by reduced expression of epithelial RelA. Likewise, expression of
RelA and pIgR were significant contributors to homeostatic PC1 in models of acute and
chronic experimental colitis, as well as human CD.
An important observation in this work is that loss of epithelial MyD88 signaling
was associated with alterations in the composition of the gut microbiota. Interestingly,
similar compositional changes have been observed in human IBD patients196. Altered
host factors that are believed to impact commensal bacteria in IBD patients include
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increased intestinal permeability, decreased production of antimicrobial peptides and
aberrant SIgA responses196, all of which were observed in MyD88∆IEC mice. Specifically,
IgA is known to have a role in shaping the composition of the microbiota by
preferentially promoting the maintenance of beneficial and symbiotic bacterial
communities19,211. In contrast, the composition of the microbiota has been shown to alter
the production and transcytosis of IgA46,212. Taken together, our findings identify a novel
role for epithelial MyD88 signaling in shaping the composition of the gut microbiota, at
least in part by regulating pIgR expression and IgA transport. This idea highlights the
complexity and importance of epithelial cells in integrating bacterial signals, as well as
immune cell interactions, to promote intestinal homeostasis.

MyD88 and TLR independent signaling pathways in the regulation of pIgR
expression
It should be noted that pIgR expression was significantly reduced in epithelial
cells from MyD88∆IEC mice, not abolished. Inhibiting the binding of E.coli LPS to TLR4
did appear to completely abolish the induction of pIgR, implying TLR4 signaling is
required in response to commensal bacteria. However, TLR4 utilizes both MyD88 and
Trif to initiate target gene transcription. Likewise, while shRNA mediated knockdown of
MyD88 in HT-29 cells resulted in reduced expression of pIgR in unstimulated cells and
reduced upregulation of pIgR expression in response to E.coli stimulation, it did not
completely abolish this response. Furthermore, work presented here, as well as previous
studies44,141, clearly demonstrates that TLR3 signaling, which is Trif-dependent and
MyD88-independent, induces pIgR expression in vitro; however the specific contribution
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of the Trif-dependent signaling pathway was not examined in these studies.
Interestingly¸ this work, as well as previous work from the lab141, has shown that
stimulation of TLR3 in HT-29 cells elicits a much stronger pro-inflammatory response
than stimulation of TLR4, even though the induction of pIgR mRNA is similar. Thus, it
is probable that the Trif-dependent pathway, as well as additional signaling pathways, is
responsible for maintaining the reduced level of pIgR expression observed in MyD88∆IEC
mice, while the levels of most pro-inflammatory chemokines and cytokines remained
unchanged. However, it has been demonstrated that Trif-\- bone marrow chimeras display
no detectable differences in response to DSS treatment158, indicating TRIF signaling does
not play a significant role in the setting of acute experimental colitis. Therefore, while
TRIF-dependent signaling can induce pIgR expression, it probably plays a minor role
during intestinal inflammation.
Importantly, as demonstrated here, one common feature of the MyD88, TRIF and
TNF signaling pathways in the induction of pIgR expression is the activation of NF-κB.
While the MAPK signaling pathway contributed to the induction of the pro-inflammatory
response, NF-κB was solely required for the induction of pIgR expression. Accordingly,
it would be interesting to examine pIgR expression in NEMO∆IEC mice. Similar to
MyD88∆IEC mice, reduced expression of antimicrobial peptides and increased bacterial
translocation was observed in NEMO∆IEC mice34. However, unlike MyD88∆IEC mice,
NEMO∆IEC mice develop severe spontaneous intestinal inflammation. Interestingly,
crossing NEMO∆IEC mice with MyD88 deficient mice prevented the development of
intestinal inflammation, demonstrating that bacterial-dependent TLR signaling is
essential for the development of intestinal inflammation in this model34. We have made
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the observation that downregulation of pIgR expression is correlated with disease
severity in IBD patients and mouse models of colitis; therefore it would be hypothesized
that pIgR expression and IgA transport would be greatly diminished in NEMO∆IEC mice,
and that this defect could contribute to disease severity.
Additional studies have demonstrated that host cytokines, including IL-4, IL-1,
IFN-γ, TNF, and IL-17 can also induce pIgR expression in vitro44,160,213 in a TLRindependent manner. IL-4, IFN- γ, and TNF have been shown to work synergistically to
induce pIgR expression44, suggesting cooperativity between host factors to maintain high
pIgR expression. It is likely that TLR-independent pathways are also affected in
MyD88∆IEC mice. In particular, IL-1, whose receptor signals through MyD88 and is a
MyD88 target gene, is a prominent pro-inflammatory cytokine released by macrophages
that are recruited to the lamina propria in response to bacterial sampling and epithelial
penetration214. IECs secrete IL-1 in an autocrine and paracrine manner in response to
bacterial stimulation215. Here we observed that MyD88∆IEC mice were unable to
upregulate epithelial IL-1 expression in response to DSS colitis. Accordingly, it is
possible that the reduction in pIgR expression and IgA transport in MyD88∆IEC mice is, in
part, due to an indirect effect of the loss of bacteria-induced MyD88 signaling, resulting
in the inability to upregulate and respond to IL-1. Consistent with this line of thinking,
MyD88∆IEC mice were unable to upregulate epithelial TNF expression in response to DSS
colitis, which was associated with increased disease severity. As we have shown here,
TNF-dependent activation of NF-κB is a strong inducer of pIgR expression in IECs.
Interestingly, it has previously been shown that chronic exposure of IECs to TNF in a cell
culture model of chronic inflammation significantly increases pIgR mRNA stability143.
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Therefore, the inability of MyD88∆IEC to upregulate epithelial TLR-induced TNF
expression would also impair autocrine TNF signaling in IECs, further disabling the
induction of pIgR expression and altering mRNA stability. Alternatively, MyD88∆IEC
mice had increased histological inflammatory scores, including an increase in
inflammatory immune cell infiltration into the lamina propria in response to DSS colitis.
While gene expression was not analyzed in lamina propria immune cells, these
inflammatory conditions are generally associated with increased production of
inflammatory cytokines, including TNF, by macrophages and activated T cells. Thus,
production of TNF, as well as other inflammatory stimuli, by MyD88-sufficient immune
cells could signal in a paracrine fashion to induce pIgR expression in IECs, independent
of epithelial MyD88 signaling, which could partially account for the pIgR expression in
MyD88∆IEC mice. Nonetheless, the capacity of such diverse factors, as well as the
utilization of several different signaling pathways, to induce pIgR expression suggests
that maintaining high levels of pIgR and transport of SIgA and SC is of significant
evolutionary importance for host fitness.

Communication between all neighbors is required to prevent translocation of
opportunistic bacteria.
As previously mentioned, a significant finding in this work is that loss of
epithelial-MyD88 signaling caused increased translocation of bacteria to the MLN. It has
been proposed that low numbers of commensal bacteria continuously translocate the
epithelial barrier in healthy immunocompetent hosts; however, these bacteria are
generally killed en route or within the lymphoid organ, rarely ever establishing a
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persistent presence216. This is not the case in MyD88∆IEC mice. Three primary
mechanisms that promote the translocation of enteric bacteria from the intestine have
been identified: Overgrowth of intestinal bacteria, deficiencies in host immune system,
and increased epithelial permeability216. While an overgrowth of K. pneumoniae was not
observed in MyD88 mice, multiple defects in innate immunity as well as increased
epithelial permeability were observed. While these primary defects in epithelial defenses
are central to the translocation of intestinal bacteria, cell-mediated immunity, including
macrophages, neutrophils and T cells in the lamina propria are involved in reducing
bacterial translocation216. Previous studies have demonstrated that the depletion of these
cells types in the lamina propria promoted the translocation of E.coli into the MLN216,217.
It has been suggested that epithelial TLR signaling is responsible for releasing soluble
factors that regulate the development of secondary lymphoid structures, recruitment of
immune cells to the lamina propria, as well as antigen sampling by DCs1,6,218,219. It is
likely that a loss of MyD88 signaling in epithelial cells affects the development,
recruitment and function of MyD88-sufficient immune cells. This idea is supported by
the results from Ismail et al.192who found that expression of RegIII-γ in small intestinal
γδ intraepithelial lymphocytes (IELs) was dependent on epithelial-specific MyD88
signaling, but was not dependent on expression of MyD88 within the IELs themselves.
Thus, not only does loss of epithelial MyD88 signaling cause defects in epithelial
defenses, it may also lead to lamina propria immune cell dysfunction, further promoting
bacterial translocation and susceptibility to intestinal inflammation.
Importantly, a dramatic increase in the translocation of Klebsiella pneumoniae
was observed in MLN from MyD88∆IEC mice. This bacterial species is the most clinically
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important member of the Klebsiella genus of the family Enterobacteriaceae, due to its
role in nosocomial lung and intestinal infections in pediatric patients220,221. It has
recently been shown that oral infection with K. pneumoniae exacerbated intestinal
inflammation in DSS colitis222. While the technique used to identify bacteria in the MLN
only allows the identification of live culturable bacteria, the fact that translocation of K
pneumoniae was observed in >95% of MyD88∆IEC mice and very rarely in MyD88sufficient mice indicates that epithelial MyD88 signaling may have general and specific
roles in antibacterial immunity. K. pneumoniae is an encapsulated bacterium. This
capsule is considered a virulence factor because it prevents desiccation and phagocytosis
by host immune phagocytes and thus enhances the ability of the bacteria to cause disease.
Accordingly, it is possible that loss of epithelial MyD88 signaling specifically increases
susceptibility to resilient opportunistic bacteria. While facultative, encapsulated anaerobic
bacteria in the Enterobacteriacceae family are considered to translocate at high
efficiency, both E. coli and Proteus mirabilis are thought to be the most efficient at
translocation216,223. However, increased translocation of E. coli, and/or an overgrowth of
either E. coli or Proteus mirabilis, was not observed in MyD88∆IEC mice. Taken together,
these results support the idea that epithelial MyD88 signaling is required to defend
against K. pneumoniae adherence and penetration of the epithelial layer, as well as
indirectly required to efficiently kill bacteria that have penetrated the epithelial barrier.
Bacterial translocation is considered an important early step in the pathogenesis of
opportunistic infections216. Although there have been recent reports of MyD88-dependent
immune responses to lung infection with K. pneumoniae195,224, the role of MyD88
signaling in enteric infections with this opportunistic pathogen has not been studied.
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While we detected significant numbers of K. pneumoniae in the MLNs of MyD88∆IEC
mice, we were unable to detect these bacteria in the spleen, suggesting that the
antibacterial activity of MyD88-sufficient immune cells was sufficient to prevent
systemic infection. Therefore while this suboptimal immunity of MyD88∆IEC mice may
be sufficient to control the numbers of K. pneumoniae normally found in the commensal
gut microbiota, it may be insufficient to control larger numbers of K. pneumoniae.
Accordingly, it would be hypothesized that MyD88∆IEC mice would be more susceptible
than MyD88Flox mice to enteric infection with K. pneumoniae. The results could offer the
potential to increase our understanding of the pathogenesis of opportunistic enteric
infections in immunocompromised individuals.

Role of MyD88-sufficient lamina propria immune cells in the regulation of intestinal
homeostasis.
One important aspect that was not addressed in these studies is the effect of loss
of epithelial MyD88 signaling on MyD88-sufficient immune cells of the lamina propria.
As previously mentioned in this chapter, it is possibly that loss of epithelial MyD88
signaling could have indirect effects on the production of SIgA. However, expression of
B cell activating factor, BAFF (Tnsf13b), as well as the lymphocyte growth factor thymic
stromal lymphopoietin (TSLP), in isolated ECs from MyD88Flox and MyD88∆IEC mice
were below the detectable limit. It would be worthwhile to compare the expression of
other epithelial-derived factors that influence B cell differentiation, such as a proliferating
inducing ligand (APRIL), in MyD88Flox and MyD88∆IEC mice. APRIL has been shown to
be released by IECs in response to TLR signaling and can directly induce B cell
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differentiation225. Furthermore, while immunofluorescence analysis of IgA expression in
colonic sections did not reveal differences in the presence of IgA+ plasma cells in the
lamina propria, the presence of additional immune cell types was not investigated. It
would be valuable to analyze the cellular composition of immune cells isolated from the
lamina propria of MyD88Flox and MyD88∆IEC mice. As previously discussed, while the
translocation of bacteria, in particular K. pneumoniae, observed in MyD88∆IEC mice is a
result of defective epithelial barrier function, the ability of these bacteria to survive transit
to the MLN suggests an impairment of lamina propria immune cells to efficiently
contain these bacteria that have penetrated the epithelium. For example, impairment in
the recruitment of DCs and T cell into the lamina propria could also indirectly effect the
production of SIgA. Analyzing the cellular composition of the lamina propria immune
cells may provide insight into the cell-types responsible for these antibacterial and
immune defects.
It would also be important to analyze pro-inflammatory gene expression in
isolated lamina propria immune cells from MyD88Flox and MyD88∆IEC mice. By using a
model in which MyD88 expression is restricted to myeloid cells, Malvin et al. have
recently shown that myeloid cells, macrophages in particular, in untreated mice are in an
activated state displaying enhanced NF-κB activity226. These authors conclude that
MyD88 signaling in non-myeloid cells can inhibit myeloid cell activation. Considering
the increase in bacterial penetration of the intestinal epithelium that was observed in
MyD88∆IEC mice, it would be hypothesized that the lamina propria of MyD88∆IEC would
also contain hyperactivated-immune cells. Here we have shown that THP-1 monocytes
are hyper-responsive to TLR stimulation, as compared to HT-29 epithelial cells.
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Furthermore, it is possible that while this hyper-activated state may offer some level of
immune protection against the normal microbiota in MyD88∆IEC mice, it may be
damaging in response to the high bacterial stimulation that occurs with DSS treatment.
Accordingly, Asquith et al. demonstrated that MyD88 signaling in hematopoietic cells
were responsible for the pro-inflammatory responses that increased colitis severity scores
in these bone marrow chimeric mice159. It is possible that these effects could contribute to
the enhanced susceptibility of MyD88∆IEC mice to DSS.

Bacterial-dependent signaling by IECs regulates intestinal homeostasis and
inflammation
Taken together, the results presented here suggest a model in which maintenance
of intestinal homeostasis requires active communication among the microbiota, epithelial
cells and immune cells. However, while communication must occur, physical and
immunological barriers must be maintained. Protection against bacterial invasion and the
development of inflammation in the intestine is dependent on the resident microbiota, the
mucus layer containing SIgA and antimicrobial peptides, and the monolayer of IECs that
provide a physical and innate immune barrier. Here we demonstrate that MyD88
signaling in IECs is a main regulator of these processes in the colon (Figure 6-1A).
Epithelial MyD88 signaling regulates the expression of Muc-2, the main structural
component of colonic mucus, as well as the expression of antimicrobial peptides.
Importantly, MyD88 signaling in epithelial cells regulates the expression of pIgR and the
transport of SIgA. In response to E. coli, the regulation of pIgR induction is dependent on
the TLR4-activation of NF-κB. However, when dysregulation of these defenses occur,
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bacterial translocation and intestinal inflammation can result (Figure 6-1B). Accordingly,
the loss of epithelial MyD88 signaling leads to reduced mucin secretion, reduced mucusassociated antimicrobial activity, reduced transcytosis of SIgA and increased epithelial
permeability. These impairments in antibacterial and innate immunity result in alterations
in the composition of the resident microbiota, increased numbers of mucus-associated
bacteria and increased bacterial translocation to the mesenteric lymph nodes. The
inability to maintain homeostasis with the intestinal microbiota increases the host’s
susceptibility to intestinal inflammation and systemic infection. Notably, sustained
reduction of pIgR expression and altered transport of SIgA are characteristic of intestinal
inflammation and further exacerbates disease. Taken together, these results highlight the
critical role of intestinal epithelial cells in maintaining intestinal homeostasis and suggest
that changes in IEC gene expression and function may be central to understanding the
underlying mechanisms of intestinal inflammation and disease. As a result, a
multifactorial approach to examine epithelial gene expression may be the most
informative for the diagnosis of intestinal disease and for evaluating potential therapeutic
options. These results provide insight into the importance of the complex relationships
between bacteria and IECs, as well as IECs and immune cells, and offer evidence for the
continued investigations into potential therapeutic strategies. Thus in the intestine, good
epithelial fences do make good neighbors.
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Figure 6-1 Bacterial-dependent signaling by IEC is required to maintain intestinal
homeostasis. (A) Under homeostatic conditions, colonic epithelial cells maintain a
physical and immunological barrier. Bacterial-dependent MyD88 signaling regulates
muc-2 production in goblet cells; regulates expression of antimicrobial peptides;
regulates the expression of pIgR and the transport of SIgA via activation of NF-κB; and
maintains an impermeable epithelial barrier. (B) Loss of colonic epithelial MyD88
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Figure 6-1 (continued) expression results in dysregulation of Muc-2, AMPs, and pIgR
expression as well as impairs SIgA transport and increases epithelial permeability. These
defects cause increased bacterial adherence and translocation, increasing the host’s
susceptibility to intestinal inflammation. (Adapted with permission from Hooper et al.
Nat. Rev. Immunol. 10(3):159-69 2010)
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